<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CNU</journal-id>
<journal-id journal-id-type="hwp">spcnu</journal-id>
<journal-title>European Journal of Cardiovascular Nursing</journal-title>
<issn pub-type="ppub">1474-5151</issn>
<issn pub-type="epub">1873-1953</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1474515112470046</article-id>
<article-id pub-id-type="publisher-id">10.1177_1474515112470046</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Phenotypic profiling of cognitive impairment risk among patients with heart failure: a literature review of the usefulness of cardiac-related variables</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Jurgens</surname><given-names>Corrine Y</given-names></name>
<xref ref-type="aff" rid="aff1-1474515112470046">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Faulkner</surname><given-names>Kenneth M</given-names></name>
<xref ref-type="aff" rid="aff1-1474515112470046">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Lee</surname><given-names>Christopher S</given-names></name>
<xref ref-type="aff" rid="aff2-1474515112470046">2</xref>
</contrib>
</contrib-group>
<aff id="aff1-1474515112470046"><label>1</label>Stony Brook University, USA</aff>
<aff id="aff2-1474515112470046"><label>2</label>Oregon Health Sciences University, Portland, USA</aff>
<author-notes>
<corresp id="corresp1-1474515112470046">Corrine Y Jurgens, Stony Brook University, School of Nursing, HSC L2-246, Stony Brook, NY 11794-8240, USA. Email: <email>corrine.jurgens@stonybrook.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>4</month>
<year>2013</year>
</pub-date>
<volume>12</volume>
<issue>2</issue>
<fpage>109</fpage>
<lpage>131</lpage>
<history>
<date date-type="received">
<day>20</day>
<month>3</month>
<year>2012</year>
</date>
<date date-type="rev-recd">
<day>8</day>
<month>10</month>
<year>2012</year>
</date>
<date date-type="accepted">
<day>13</day>
<month>11</month>
<year>2012</year>
</date>
</history>
<permissions>
<copyright-statement>© The European Society of Cardiology 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">European Society of Cardiology</copyright-holder>
</permissions>
<abstract>
<sec id="section1-1474515112470046">
<title>Background:</title>
<p>Mild cognitive impairment among patients with heart failure can be subtle. Heart failure-related variables such as ejection fraction, low systolic blood pressure and functional status are reportedly associated with cognitive impairment among heart failure patients. The purpose of this literature review was to examine the value of cardiac variables commonly assessed during heart failure-related hospitalizations for a phenotypic profile of the risk of cognitive impairment.</p>
</sec>
<sec id="section2-1474515112470046">
<title>Method:</title>
<p>A literature review of primary research studies was conducted. Electronic databases (PubMed and CINAHL) were searched using the keywords heart failure, blood pressure, ejection fraction, functional status, and B-type natriuretic peptide (BNP) in combination with the terms cognition, cognitive function, cognitive dysfunction, and cognitive impairment.</p>
</sec>
<sec id="section3-1474515112470046">
<title>Results:</title>
<p>Thirty-seven studies met the inclusion criteria. Evidence supports the potential utility of lower ejection fraction, lower blood pressure and functional status and elevated B-type natriuretic peptide as a phenotypic profile for an increased risk of cognitive impairment.</p>
</sec>
<sec id="section4-1474515112470046">
<title>Implications:</title>
<p>If the risk for cognitive impairment is suspected, specific evaluations of cognition can be performed. For community-dwelling heart failure patients with mild cognitive impairment, more intense interventions to support self-care, increased family involvement and more frequent follow up may be necessary.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Heart failure</kwd>
<kwd>cognitive impairment</kwd>
<kwd>cardiac-related variables</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section5-1474515112470046" sec-type="intro">
<title>Introduction</title>
<p>Heart failure (HF) is a significant health problem in the United States with an estimated 5.7 million Americans currently diagnosed with HF.<sup><xref ref-type="bibr" rid="bibr1-1474515112470046">1</xref></sup> As it is the most common cause of hospitalization and rehospitalization in older adults, efforts to limit repeated admissions among community-dwelling patients include optimizing medical management and improving self-care.<sup><xref ref-type="bibr" rid="bibr2-1474515112470046">2</xref>,<xref ref-type="bibr" rid="bibr3-1474515112470046">3</xref></sup> However, self-care is challenging for many reasons, including complexity of medical regimens and non-specificity of HF symptoms. Further complicating self-care capacity is the prevalence of cognitive impairment,<sup><xref ref-type="bibr" rid="bibr4-1474515112470046">4</xref>,<xref ref-type="bibr" rid="bibr5-1474515112470046">5</xref></sup> reported as ranging from 25% to 80% in the adult HF population.<sup><xref ref-type="bibr" rid="bibr5-1474515112470046">5</xref><xref ref-type="bibr" rid="bibr6-1474515112470046"/>-<xref ref-type="bibr" rid="bibr7-1474515112470046">7</xref></sup> The etiology of cognitive impairment in patients with HF is not fully understood, but is believed to be due to either a chronic or an intermittent decrease in cerebral perfusion as a result of a failing heart.<sup><xref ref-type="bibr" rid="bibr7-1474515112470046">7</xref><xref ref-type="bibr" rid="bibr8-1474515112470046"/>-<xref ref-type="bibr" rid="bibr9-1474515112470046">9</xref></sup> Associated with decreased cerebral blood flow is a sympathetic nervous system response which attempts to compensate for decreased perfusion.<sup><xref ref-type="bibr" rid="bibr10-1474515112470046">10</xref></sup> Brain imaging of patients with advanced HF has shown significantly decreased gray matter in areas corresponding to important aspects of cognitive function; specifically, the frontal cortex and the area surrounding the hippocampus.<sup><xref ref-type="bibr" rid="bibr11-1474515112470046">11</xref></sup> The degree of cognitive impairment is highly variable, extending from sub-clinical to severe. The clinical criteria for those patients with subclinical or mild cognitive impairment include a reported decline in cognitive function over the course of a year, clinically measurable deficits in memory or another cognitive domain, absence of significant impact on daily activities and no signs of overt dementia.<sup><xref ref-type="bibr" rid="bibr12-1474515112470046">12</xref></sup> Although HF patients with mild cognitive impairment may be capable of doing many activities of daily living, capacity for self-care may be limited.<sup><xref ref-type="bibr" rid="bibr9-1474515112470046">9</xref>,<xref ref-type="bibr" rid="bibr12-1474515112470046">12</xref><xref ref-type="bibr" rid="bibr13-1474515112470046"/>-<xref ref-type="bibr" rid="bibr14-1474515112470046">14</xref></sup></p>
<p>Self-care is defined as a patient’s active involvement in the management of their disease.<sup><xref ref-type="bibr" rid="bibr9-1474515112470046">9</xref>,<xref ref-type="bibr" rid="bibr15-1474515112470046">15</xref></sup> As described by Riegel et al., self-care is a naturalistic decision making process where people make decisions in their real world environments.<sup><xref ref-type="bibr" rid="bibr2-1474515112470046">2</xref></sup> Patients with HF need to make daily decisions about medications and dietary choices. In addition, patients need to recognize and make decisions in response to HF symptoms when they occur. Cognitive function consists of several domains including memory, language, attention, visual/spatial/constructional, psychomotor speed and executive functioning.<sup><xref ref-type="bibr" rid="bibr6-1474515112470046">6</xref></sup> Patients with deficits in cognitive functioning, particularly executive function, memory and attention, are at risk for poor self-care.<sup><xref ref-type="bibr" rid="bibr9-1474515112470046">9</xref>,<xref ref-type="bibr" rid="bibr15-1474515112470046">15</xref></sup> Descriptions of the cognitive domains commonly associated with self-care are listed in <xref ref-type="table" rid="table1-1474515112470046">Table 1</xref>, together with the tests used in assessing that domain. Impairments in these domains make it more difficult for HF patients to follow complex plans of care, such as medication management and appropriate dietary practices.<sup><xref ref-type="bibr" rid="bibr15-1474515112470046">15</xref>,<xref ref-type="bibr" rid="bibr16-1474515112470046">16</xref></sup> In addition, deficiencies in these domains make it difficult for patients to identify symptoms and make complex decisions about management of HF exacerbations.<sup><xref ref-type="bibr" rid="bibr9-1474515112470046">9</xref></sup> Consequently, deficits in cognition in the areas of decision-making may compromise self-care. Cognitive impairment in this population can be subtle. However, reliable neurocognitive testing typically used to detect mild cognitive impairment requires extensive training and time.<sup><xref ref-type="bibr" rid="bibr10-1474515112470046">10</xref>,<xref ref-type="bibr" rid="bibr17-1474515112470046">17</xref></sup> Conducting this type of testing in the context of hospitalized patients with HF is likely impractical in routine assessments. A reliable method of identifying patients at risk for mild cognitive impairment using common HF-related assessments has not been reported.</p>
<table-wrap id="table1-1474515112470046" position="float">
<label>Table 1.</label>
<caption>
<p>Cognitive domains and neurocognitive testing.</p>
</caption>
<graphic alternate-form-of="table1-1474515112470046" xlink:href="10.1177_1474515112470046-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Domain</th>
<th align="left">Purpose/relationship to self-care</th>
<th align="left">Commonly used neurocognitive tests</th>
</tr>
</thead>
<tbody>
<tr>
<td>Global function<sup><xref ref-type="bibr" rid="bibr13-1474515112470046">13</xref>,<xref ref-type="bibr" rid="bibr25-1474515112470046">25</xref>,<xref ref-type="bibr" rid="bibr26-1474515112470046">26</xref>,<xref ref-type="bibr" rid="bibr33-1474515112470046">33</xref><xref ref-type="bibr" rid="bibr34-1474515112470046"/>-<xref ref-type="bibr" rid="bibr35-1474515112470046">35</xref></sup></td>
<td>Global cognitive ability.</td>
<td><list id="list1-1474515112470046" list-type="bullet">
<list-item><p>Mini Mental State Exam (MMSE)</p></list-item>
<list-item><p>Montreal Cognitive Assessment (MoCA)</p></list-item>
<list-item><p>Repeatable Battery for the Assessment of Neurocognitive Status (RBANS)</p></list-item>
</list></td>
</tr>
<tr>
<td>Memory<sup><xref ref-type="bibr" rid="bibr5-1474515112470046">5</xref>,<xref ref-type="bibr" rid="bibr6-1474515112470046">6</xref></sup></td>
<td>Ability to recall information, such as how to titrate medications or when to seek help.<break/> Several subcategories include:
<list id="list2-1474515112470046" list-type="bullet">
<list-item><p>Working memory</p></list-item>
<list-item><p>Immediate memory</p></list-item>
<list-item><p>Delayed memory</p></list-item>
</list></td>
<td><list id="list3-1474515112470046" list-type="bullet">
<list-item><p>Digit Span Test</p></list-item>
<list-item><p>Corsi’s Block Tapping Test</p></list-item>
<list-item><p>Wechsler Memory Scale</p></list-item>
<list-item><p>Rey-Osterrieth Complex Figure Recognition and Recall Tests</p></list-item>
<list-item><p>The Hopkins Verbal Learning Test</p></list-item>
<list-item><p>Rey Auditory Verbal Learning Test</p></list-item>
</list></td>
</tr>
<tr>
<td>Executive function<sup><xref ref-type="bibr" rid="bibr5-1474515112470046">5</xref>,<xref ref-type="bibr" rid="bibr6-1474515112470046">6</xref></sup></td>
<td>Ability to think in an abstract way, appreciate context and respond to a given scenario, such as when subtle signs of disease progression are present. Also, the use of proper restraint, when necessary.</td>
<td><list id="list4-1474515112470046" list-type="bullet">
<list-item><p>Trail Making Test Part B (TMT-B)</p></list-item>
<list-item><p>Controlled Oral Word Test (COWA)</p></list-item>
<list-item><p>Letter Fluency</p></list-item>
<list-item><p>Wechsler Adult Intelligence Scale Letter Number Sequencing test (WAIS-III LN)</p></list-item>
</list></td>
</tr>
<tr>
<td>Attention</td>
<td>Ability to focus on one thing, such as education about disease management, while ignoring others.</td>
<td><list id="list5-1474515112470046" list-type="bullet">
<list-item><p>Trail Making Test Part A (TMT-A)</p></list-item>
<list-item><p>Digit Span Test</p></list-item>
<list-item><p>TMT-B</p></list-item>
<list-item><p>Digit Symbol Test</p></list-item>
<list-item><p>Stroop Color–Word Test</p></list-item>
</list></td>
</tr>
<tr>
<td>Visual/spatial/constructional<sup><xref ref-type="bibr" rid="bibr6-1474515112470046">6</xref>,<xref ref-type="bibr" rid="bibr24-1474515112470046">24</xref></sup></td>
<td>Ability to perceive something visually, process it and physically react to it.</td>
<td><list id="list6-1474515112470046" list-type="bullet">
<list-item><p>Rey–Osterrieth Complex Figure Copy Test</p></list-item>
<list-item><p>Block Design Test</p></list-item>
</list></td>
</tr>
</tbody>
</table>
</table-wrap>
<p>HF-related variables such as ejection fraction (EF), low systolic blood pressure (BP) and functional status are reportedly associated with cognitive impairment among HF patients. These variables may provide a phenotypic profile of those at risk for cognitive impairment. Identification of readily available routinely assessed HF metrics would be an asset when planning interventions to support self-care (e.g. family involvement, time to follow up, dose of educational intervention). Accordingly, the purpose of this literature review was to examine the value of cardiac variables commonly assessed during HF-related hospitalizations for a phenotypic profile of cognitive impairment risk.</p>
</sec>
<sec id="section6-1474515112470046" sec-type="methods">
<title>Method</title>
<p>Electronic databases (PubMed, CINAHL, Medline and PsychINFO) were searched using the key words heart failure, blood pressure, ejection fraction, functional status, and B natriuretic peptide (BNP) in combination with the terms cognition, cognitive function, cognitive dysfunction, and cognitive impairment. A hand search also was conducted on studies retrieved. The inclusion criteria were: (a) samples with HF patients, and (b) studies published in English reporting on relationships of the variables of interest. Studies reporting cognition as a predictor of mortality were excluded, as the purpose was to examine predictors or correlates of cognitive status. Years searched was not limited. Based on the literature to date, the most commonly reported HF-related variables studied in relation to cognition include severity of systolic dysfunction (EF), BP, functional status (e.g. New York Heart Association (NYHA) class) and cardiac-related laboratory tests. To support the reliability and validity of studies used for the analysis, the authors (CYJ and KMF) reviewed and selected studies by reviewing the abstracts first followed by review of the full text versions. Consensus was reached for all studies included in the analysis. Three hundred and six citations were evaluated for inclusion. Duplicate citations (<italic>n</italic>=150), non-research reports (<italic>n</italic>=20), studies not available in English (<italic>n</italic>=2) and studies without analysis of the variables of interest were excluded (<italic>n</italic>=97) (<xref ref-type="fig" rid="fig1-1474515112470046">Figure 1</xref>). As this is a novel line of inquiry, extrapolating relationships between cognition and the variables of interest necessitated including some studies with small sample sizes of HF patients. Thirty-seven studies were identified for inclusion in this review. Levels of evidence were determined using the method outlined by Melnyk and Fineout-Overholt (<xref ref-type="table" rid="table2-1474515112470046">Table 2</xref>).<sup><xref ref-type="bibr" rid="bibr18-1474515112470046">18</xref></sup></p>
<fig id="fig1-1474515112470046" position="float">
<label>Figure 1.</label>
<caption>
<p>PRISMA flowchart for selection of evidence.</p>
</caption>
<graphic xlink:href="10.1177_1474515112470046-fig1.tif"/>
</fig>
<table-wrap id="table2-1474515112470046" position="float">
<label>Table 2.</label>
<caption>
<p>Levels of evidence.<sup><xref ref-type="bibr" rid="bibr18-1474515112470046">18</xref></sup></p>
</caption>
<graphic alternate-form-of="table2-1474515112470046" xlink:href="10.1177_1474515112470046-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
</colgroup>
<tbody>
<tr>
<td>I. Systematic review or meta-analysis of randomized controlled trials</td>
</tr>
<tr>
<td>II. Randomized control trial</td>
</tr>
<tr>
<td>III. Controlled trials without randomization</td>
</tr>
<tr>
<td>IV. Case control or cohort studies</td>
</tr>
<tr>
<td>V. Systematic reviews of descriptive or qualitative studies</td>
</tr>
<tr>
<td>VI. Descriptive or qualitative study</td>
</tr>
<tr>
<td>VII. Expert opinion</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="section7-1474515112470046" sec-type="results">
<title>Results</title>
<sec id="section8-1474515112470046">
<title>Cognition and EF</title>
<p>Left ventricular EF was frequently investigated (<italic>n</italic>=23 studies) in relation to cognition, as EF is a direct measure of the heart’s pumping ability (<xref ref-type="table" rid="table3-1474515112470046">Table 3</xref>). Investigators hypothesized that a decreased EF would contribute to decreased cerebral perfusion, and ultimately cognitive impairment. A 2007 systematic review by Vogels and colleagues identified inconsistencies in the relationship between EF and cognitive impairment;<sup><xref ref-type="bibr" rid="bibr5-1474515112470046">5</xref></sup> however, more recent studies support this relationship.<sup><xref ref-type="bibr" rid="bibr4-1474515112470046">4</xref>,<xref ref-type="bibr" rid="bibr17-1474515112470046">17</xref>,<xref ref-type="bibr" rid="bibr19-1474515112470046">19</xref><xref ref-type="bibr" rid="bibr20-1474515112470046"/><xref ref-type="bibr" rid="bibr21-1474515112470046"/><xref ref-type="bibr" rid="bibr22-1474515112470046"/><xref ref-type="bibr" rid="bibr23-1474515112470046"/><xref ref-type="bibr" rid="bibr24-1474515112470046"/><xref ref-type="bibr" rid="bibr25-1474515112470046"/><xref ref-type="bibr" rid="bibr26-1474515112470046"/><xref ref-type="bibr" rid="bibr27-1474515112470046"/><xref ref-type="bibr" rid="bibr28-1474515112470046"/><xref ref-type="bibr" rid="bibr29-1474515112470046"/><xref ref-type="bibr" rid="bibr30-1474515112470046"/><xref ref-type="bibr" rid="bibr31-1474515112470046"/>-<xref ref-type="bibr" rid="bibr32-1474515112470046">32</xref></sup></p>
<table-wrap id="table3-1474515112470046" position="float">
<label>Table 3.</label>
<caption>
<p>Cognition and EF.</p>
</caption>
<graphic alternate-form-of="table3-1474515112470046" xlink:href="10.1177_1474515112470046-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Study</th>
<th align="left">Design</th>
<th align="left">Sample</th>
<th align="left">Cognitive measures</th>
<th align="left">Summary of results</th>
</tr>
</thead>
<tbody>
<tr>
<td>Almeida and Tamai (2001)<sup><xref ref-type="bibr" rid="bibr4-1474515112470046">4</xref></sup><break/><italic>Level of evidence: IV</italic><break/><italic>Brazil</italic></td>
<td>Prospective, cross-sectional, case-control</td>
<td><italic>N</italic>=50 elders with advanced HF<break/><italic>N</italic>=30 elderly controls<break/>Mean age 67.3–76.7<break/>HF diagnosis:<break/>systolic HF using echocardiogram</td>
<td>MMSE<break/>CAMDEX/CAMCOG<break/>Digit Span<break/>Digit Symbol<break/>WAIS<break/>TMT-A<break/>TMT-B<break/><italic>Scores adjusted for age in analysis</italic></td>
<td>HF patients had lower cognitive scores and lower attention than controls (MMSE <italic>F</italic>=15.16, <italic>p</italic>=0.011; CAMCOG <italic>F</italic>=24.89, <italic>p</italic>=&lt;0.001)<break/>EF significantly associated with cognition:<break/>CAMCOG (rho 0.40, <italic>p</italic>=&lt;0.001) MMSE (rho 0.29, <italic>p</italic>=0.011)<break/>Digit Span (rho= 0.25, <italic>p</italic>=0.002) Digit Symbol (rho=0.45, <italic>p</italic>=&lt;0.001)<break/>TMT-A (rho= −0.28, <italic>p</italic>=0.013)<break/>TMT-B (rho= −0.34, <italic>p</italic>=0.003)<break/>EF significantly associated with cognitive scores and was strongest predictor of cognitive impairment (OR 7.61, 95% CI 2.03–28.48)</td>
</tr>
<tr>
<td>Almeida et al. (2012)<sup><xref ref-type="bibr" rid="bibr36-1474515112470046">36</xref></sup><break/><italic>Level of evidence: IV</italic><break/><italic>Australia</italic></td>
<td>Longitudinal case control</td>
<td><italic>N</italic>=77 HF<break/><italic>N</italic>=73 heart disease<break/><italic>N</italic>=81 controls<break/>Mean age between groups 67.8 to 69.3 (range 45–86)<break/>HF diagnosis: EF &lt;40% by echocardiogram and symptoms of HF</td>
<td>MMSE<break/>CAMCOG<break/>California Verbal Learning Test<break/>Digit Copy<break/>Digit Coding<break/>WAIS<break/><italic>Scores adjusted for age, gender and IQ in analysis</italic></td>
<td>CAMCOG scores were lower in HF patients compared with controls (95% CI −1.7, −0.1; <italic>p</italic>=0.022)<break/>EF did not fully explain decline in CAMCOG in HF patients when compared with controls<break/>(95% CI = −4.0, −0.0; <italic>p</italic>=0.05)</td>
</tr>
<tr>
<td>Argiriadou et al. (2010)<sup><xref ref-type="bibr" rid="bibr19-1474515112470046">19</xref></sup><break/><italic>Level of evidence: VI</italic><break/><italic>Greece</italic></td>
<td>Six-month longitudinal case report</td>
<td><italic>N</italic>=1<break/>57 years of age<break/>HF diagnosis:<break/>systolic HF using<break/>echocardiogram</td>
<td>Word List Learning<break/>Digit Span (forward and backward)<break/>SCWI<break/>Symbol Digit<break/>Judgment of Line Orientation<break/>Concentration Capacity<break/>Fuld Object – Memory Evaluation<break/>Verbal Fluency<break/><italic>Effect of age and education included in analysis</italic></td>
<td>Improvement in the domains of memory, attention and learning ability following LVAD placement (increase in raw score reported)</td>
</tr>
<tr>
<td>Boodhwani et al. (2006)<sup><xref ref-type="bibr" rid="bibr20-1474515112470046">20</xref></sup><break/><italic>Level of evidence: VI</italic><break/><italic>Canada</italic></td>
<td>Longitudinal descriptive</td>
<td><italic>N</italic>=448 elders undergoing non-emergent CABG<break/>Mean age 68.3<break/>HF diagnosis:<break/>method of determining diagnosis not reported</td>
<td>Verbal List Learning<break/>Procedure (Buschke)<break/>WAIS – Revised<break/>WAIS III<break/>Digit Span<break/>TMT-A<break/>TMT-B<break/>Grooved Pegboard<break/>Symbol Digit<break/>RAVLT<break/><italic>Effect of education included in analysis</italic></td>
<td>Higher education level (OR 1.52 (95% CI 1.01–2.28), <italic>p</italic>=0.042) and abnormal LV function (OR 1.53 (95% CI 1.02–2.30), <italic>p</italic>=0.042) are predictors of cognitive decline postoperatively</td>
</tr>
<tr>
<td>Dickson et al. (2008)<sup><xref ref-type="bibr" rid="bibr21-1474515112470046">21</xref></sup><break/><italic>Level of evidence: VI</italic><break/><italic>USA</italic></td>
<td>Cross-sectional/mixed methods</td>
<td><italic>N</italic>=41 HF patients from outpatient clinics<break/>Mean age 49.17 (range 25–65)<break/>HF diagnosis:<break/>systolic, diastolic and mixed class II or III HF by EF criteria</td>
<td>Digit Symbol<break/>Probed Memory Recall<break/>Letter–Number Sequencing<break/><italic>Effect of age included in analysis</italic></td>
<td>Cognitive impairment was associated with lower EF (<italic>p</italic>=0.05) Mean EF 16%±8.94% for those cognitively impaired</td>
</tr>
<tr>
<td>Dixit et al. (2010)<sup><xref ref-type="bibr" rid="bibr22-1474515112470046">22</xref></sup><break/><italic>Level of evidence: IV</italic><break/><italic>USA</italic></td>
<td>Quasi-experimental<break/>Pretest posttest<break/>(patient own control)</td>
<td><italic>N</italic>=20 patients undergoing placement of a biventricular pacing device for CRT<break/>Mean age 54.8<break/>HF diagnosis:<break/>systolic HF using<break/>echocardiogram</td>
<td>TMT-A<break/>TMT-B<break/>Digit Span<break/>Digit Symbol<break/>HVLT – Revised<break/>COWA<break/><italic>Scores adjusted for age and education</italic></td>
<td>Mean EF improved 30% ± 10% following CRT (<italic>p</italic>&lt;0.001)<break/>Improvements in attention (Digit Span <italic>t</italic>= −2.695, <italic>p</italic>=0.015) and information processing (Digit Symbol <italic>t</italic>= −4.577, <italic>p</italic>&lt;0.001; COWA <italic>t</italic>= −3.338, <italic>p</italic>=0.004) following placement of a biventricular pacing device</td>
</tr>
<tr>
<td>Festa et al. (2011)<sup><xref ref-type="bibr" rid="bibr23-1474515112470046">23</xref></sup><break/><italic>Level of evidence: IV</italic><break/><italic>USA</italic></td>
<td>Retrospective</td>
<td><italic>N</italic>=207 HF patients<break/>Age range 17–72<break/>HF diagnosis:<break/>EF determined using echocardiogram, subjects divided into &lt;30 and ≥30</td>
<td>HVLT<break/>Brief Visuospatial Memory Test – Revised<break/>Memory Composite Score<break/>Digit Span<break/>TMT-A<break/>TMT-B<break/>COWA<break/><italic>Effect of age and education included in analysis</italic></td>
<td>Low EF was associated with lower cognitive function in participants 63 years of age or older. Among patients 63 years of older an EF&lt;30% decreased the Memory Composite Score an average of 0.95 (95% CI 0.18–1.72, <italic>p</italic>=0.02)<break/>No effect of low EF on younger population</td>
</tr>
<tr>
<td>Gottesman et al. (2010)<sup><xref ref-type="bibr" rid="bibr24-1474515112470046">24</xref></sup><break/><italic>Level of evidence: IV</italic><break/><italic>USA</italic></td>
<td>Cross-sectional</td>
<td><italic>N</italic>=234 patients with heart disease prior to CABG surgery<break/>Mean age 63.1–64.8<break/>HF diagnosis:<break/>systolic HF using<break/>echocardiogram or cardiac catheterization criteria</td>
<td>RAVLT – multiple<break/>Rey Complex Figure – multiple<break/>Block Design<break/>BNT<break/>Grooved Pegboard<break/>TMT-A<break/>TMT-B<break/>Written Alphabet<break/>MMSE – serial 7s<break/><italic>Scores adjusted for age, sex, and education</italic></td>
<td>Lower EF was associated with lower cognitive performance in motor speed (β=0.15, <italic>p</italic>=0.02), visuoconstruction (β=0.13, <italic>p</italic>=0.03) and global cognition (β=0.11, <italic>p</italic>=0.04)</td>
</tr>
<tr>
<td>Hoth et al. (2008)<sup><xref ref-type="bibr" rid="bibr26-1474515112470046">26</xref></sup><break/><italic>Level of evidence: IV</italic></td>
<td>Case-control, cross sectional descriptive</td>
<td><italic>N</italic>=31 patients with moderate to severe HF</td>
<td>RBANS global<break/>TMT-A<break/>TMT-B</td>
<td>HF patients demonstrated lower scores on tests of executive function than cardiac controls (TMT-A and -B <italic>p</italic>&lt;0.05, SCWI <italic>p</italic>&lt;0.01)</td>
</tr>
<tr>
<td><italic>USA</italic></td>
<td/>
<td><italic>N</italic>=31 age-matched cardiac controls with no HF<break/>Mean age 68.9–69.1<break/>HF diagnosis:<break/>systolic HF using<break/>EF criteria</td>
<td>COWA<break/>WAIS III<break/>SCWI<break/><italic>Scores adjusted for age. Effect of education included in analysis</italic></td>
<td>Higher EF associated with higher scores on tests of executive function (WAIS III <italic>r</italic>=0.51, <italic>p</italic>&lt;0.05, COWA <italic>r</italic>=0.48, <italic>p</italic>&lt;0.05), attention (<italic>r</italic>=0.55, <italic>p</italic>&lt;0.05) and global cognition (<italic>r</italic>=0.50, <italic>p</italic>&lt;0.05)</td>
</tr>
<tr>
<td>Hoth et al. (2010)<sup><xref ref-type="bibr" rid="bibr25-1474515112470046">25</xref></sup><break/><italic>Level of evidence: IV</italic><break/><italic>USA</italic></td>
<td>Quasi-experimental, longitudinal</td>
<td><italic>N</italic>=27 advanced HF<break/>Mean age 68.4–68.5<break/>HF diagnosis:<break/>systolic HF using<break/>echocardiogram</td>
<td>RBANS global<break/>TMT-A<break/>TMT-B<break/>COWA<break/>WAIS III Letter–Number Sequencing<break/><italic>Scores adjusted for age</italic></td>
<td>CRT placement with ≥15% improvement in EF associated with improvement in executive function (<italic>F</italic>=8.57, <italic>p</italic>=0.007), visuospatial function (<italic>F</italic>=7.52, <italic>p</italic>=0.011) and less decline in global cognition (<italic>F</italic>=5.73, <italic>p</italic>=0.024)</td>
</tr>
<tr>
<td>Jefferson et al. (2011)<sup><xref ref-type="bibr" rid="bibr27-1474515112470046">27</xref></sup><break/><italic>Level of evidence: VI</italic><break/><italic>USA</italic></td>
<td>Cross-sectional descriptive</td>
<td><italic>N</italic>=1114 HF patients <break/>Mean age 67<break/>HF diagnosis:<break/>HF using<break/>cardiac MRI</td>
<td>Logical Memory Delayed Recall<break/>Visual Reproduction Delayed Recall<break/>BNT<break/>TMT-B<break/>TMT-A<break/>Similarities Test<break/>Hooper Visual Organization Test<break/><italic>Scores adjusted for age and sex</italic></td>
<td>EF &lt;62% associated with worse delayed memory (β= −0.27±0.08, <italic>p</italic>&lt;0.001) and visuoperception (β= −0.27±0.08, <italic>p</italic>&lt;0.001)<break/>EF &gt; 73.19% associated with worse delayed memory (β= −0.17 ±0.08, <italic>p</italic>=0.029), visuoperception (β= −0.20±0.08, <italic>p</italic>=0.015) and executive function (β= −0.22±0.09, <italic>p</italic>=0.022)</td>
</tr>
<tr>
<td>Jerskey et al. (2009)<sup><xref ref-type="bibr" rid="bibr28-1474515112470046">28</xref></sup><break/><italic>Level of evidence: VI</italic><break/><italic>USA</italic></td>
<td>Cross-sectional descriptive</td>
<td><italic>N</italic>=76 cardiac outpatients<break/>(24.2% (<italic>n</italic>=18) had HF)<break/>Mean age 68.5<break/>(range 56–85)<break/>HF diagnosis: echocardiogram and medical record review</td>
<td>MMSE<break/>Adaptive Rate Continuous Performance Test (attention and processing speed)<break/>Go/No go Test (attention and executive function)<break/><italic>Scores adjusted for age and sex</italic></td>
<td>Measures of attention significantly predicted EF (vigilance β = −0.32, <italic>p</italic>=0.012; discrimination β = −0.42, <italic>p</italic>=0.039; false positive errors β= −0.51, <italic>p</italic>=0.045)</td>
</tr>
<tr>
<td>Mapelli et al. (2011)<sup><xref ref-type="bibr" rid="bibr17-1474515112470046">17</xref></sup><break/><italic>Level of evidence: VI</italic></td>
<td>Cross-sectional descriptive</td>
<td><italic>N</italic>=207 patients with end-stage cardiac disease</td>
<td>MMSE<break/>Token Test<break/>TMT-A<break/>TMT-B<break/>Digit Span<break/>Logical Story<break/>Interference Memory<break/>Cognitive Estimation<break/>Abstract Verbal Reasoning</td>
<td>Elevated LVEF associated with increased attention (<italic>r</italic>=0.17, <italic>p</italic>&lt;0.05)</td>
</tr>
<tr>
<td><italic>Italy</italic></td>
<td/>
<td>Mean age 53.33<break/>HF diagnosis:<break/>systolic HF<break/>cardiac catheterization criteria</td>
<td>Phonemic Fluency Test<break/>Clock Drawing Test<break/>Overlapping Pictures Test<break/>Spontaneous Drawing<break/>Copy Drawing<break/>Ideative and Ideomotor Praxis Test<break/><italic>Scores adjusted for age and education</italic></td>
<td>Elevated cardiac index associated with increased global cognition (<italic>r</italic>=0.20, <italic>p</italic>&lt;0.05)</td>
</tr>
<tr>
<td>Mauro et al. (2007)<sup><xref ref-type="bibr" rid="bibr37-1474515112470046">37</xref></sup><break/><italic>Level of evidence: VI</italic><break/><italic>Italy</italic></td>
<td>Cross-sectional, descriptive</td>
<td><italic>N</italic>=60 HF patients<break/>Mean age 65.5 (range 24–87)<break/>HF diagnosis:<break/>systolic and diastolic HF using echocardiogram</td>
<td>MMSE<break/>Corsi Block Tapping<break/>Prose Memory Test<break/>Visual Search Test<break/><italic>Scores adjusted for age and education</italic></td>
<td>LVEF not significantly associated with MMSE score (<italic>r</italic>=0.04, <italic>p</italic>=0.1)</td>
</tr>
<tr>
<td>Moser (1999)<sup><xref ref-type="bibr" rid="bibr29-1474515112470046">29</xref></sup><break/><italic>Level of evidence: IV</italic><break/><italic>USA</italic></td>
<td>Case-control</td>
<td><italic>N</italic>=93 patients enrolled in a cardiac rehabilitation program (34% with EF&lt;45%)<break/><italic>N</italic>=36 controls<break/>Mean age 60.94–67.58<break/>HF diagnosis:<break/>HF diagnosis using echocardiogram or cardiac catheterization criteria</td>
<td>MMSE<break/>Recognition Memory Test<break/>Similarities<break/>Digit Symbol<break/>BNT<break/>Animal Fluency<break/><italic>Effect of age, sex and education not reported</italic></td>
<td>Reduced EF was associated with lower MMSE (<italic>p</italic>&lt;0.05), BNT (<italic>p</italic>&lt;0.01), Digit Symbol (<italic>p</italic>&lt;0.01) and Recognition Memory Test (<italic>p</italic>&lt;0.05)</td>
</tr>
<tr>
<td>Petrucci et al. (2012)<sup><xref ref-type="bibr" rid="bibr30-1474515112470046">30</xref></sup><break/><italic>Level of evidence: IV</italic><break/><italic>USA</italic></td>
<td>Longitudinal experimental, pretest posttest<break/>(patient own control)</td>
<td><italic>N</italic>=126 end-stage HF patients undergoing LVAD placement<break/>Median age 55–62 (range 26–87)<break/>HF diagnosis:<break/>systolic HF using EF criteria</td>
<td>Clock Drawing Test<break/>WAIS III multiple<break/>WMS – III multiple<break/>TMT-A<break/>TMT-B<break/>BNT<break/><italic>Effect of age included in analysis</italic></td>
<td>Significant improvement in multiple cognitive domains over time following LVAD placement (<italic>p</italic>&lt;0.05)</td>
</tr>
<tr>
<td>Stanek et al. (2009)<sup><xref ref-type="bibr" rid="bibr39-1474515112470046">39</xref></sup><break/><italic>Level of evidence: VI</italic></td>
<td>Longitudinal descriptive</td>
<td><italic>N</italic>=75 older adults with cardiovascular disease</td>
<td>Global Dementia Rating Scale (DRS)</td>
<td>HF patients had improvement in DRS score over 12 months (<italic>t</italic>= −3.60, <italic>p</italic>=0.001)</td>
</tr>
<tr>
<td><italic>USA</italic></td>
<td/>
<td><italic>n</italic>=40 had HF at baseline<break/>Mean age 70 (range 53–84)<break/>HF diagnosis:<break/>clinical diagnosis or echocardiogram</td>
<td><italic>Effect of age, education and sex included in analysis</italic></td>
<td>No significant correlation between EF and DRS score (<italic>p</italic>=0.29)</td>
</tr>
<tr>
<td>Sauve et al. (2009)<sup><xref ref-type="bibr" rid="bibr38-1474515112470046">38</xref></sup><break/><italic>Level of evidence: IV</italic><break/><italic>USA</italic></td>
<td>Case-control</td>
<td><italic>N</italic>=50 patients with HF with mean EF of 27%<break/><italic>N</italic>=50 age, gender, IQ matched controls<break/>Mean age 63 and 62.5 for HF patients and controls respectively<break/>HF diagnosis:<break/>cardiac catheterization and echocardiogram</td>
<td>Neurobehavioral Cognitive Status Exam<break/>Symbol Digit<break/>Rey Auditory Verbal Learning Test<break/>COWA<break/>Finger Tapping Test<break/>Memory Scanning Test<break/>Visual Scanning Test<break/>WAIS-R Vocabulary<break/><italic>Effect of age, IQ and sex included in analysis</italic></td>
<td>Cognitive impairment identified in 46% of HF patients compared with 16% in the controls<break/>HF correlated with cognitive impairment (OR =4.47, 95% CI 1.75, 11.43; <italic>p</italic> ≤ 0.002)<break/>EF not associated with severity of cognitive impairment</td>
</tr>
<tr>
<td>Tanne et al. (2005)<sup><xref ref-type="bibr" rid="bibr31-1474515112470046">31</xref></sup><break/><italic>Level of evidence: IV</italic><break/><italic>Israel</italic></td>
<td>Longitudinal, quasi-experimental</td>
<td><italic>N</italic>=20 ambulatory patients with severe HF (Class III, LVEF ≤35%)<break/>Mean age 63 (range 39–81)<break/>HF diagnosis:<break/>clinical criteria</td>
<td>MMSE<break/>COWA<break/>TMT-A<break/>TMT-B<break/>SCWI<break/>Continuous performance test<break/>Rey–Osterrieth complex figure<break/><italic>Adjustment for age, education not reported</italic></td>
<td>Significant improvement in cardiac index (<italic>p</italic>=0.02), scores of general attention and psychomotor speed (TMT-A <italic>p</italic>=0.02, TMT-B <italic>p</italic>=0.002, SCWI <italic>p</italic>=0.04) following exercise program.<break/>Control patients who did not participate in exercise program did not show improvement (<italic>p</italic>=0.23−0.72)</td>
</tr>
<tr>
<td>van den Hurk et al. (2011)<sup><xref ref-type="bibr" rid="bibr40-1474515112470046">40</xref></sup><break/><italic>Level of evidence: IV</italic></td>
<td>Longitudinal descriptive cohort study</td>
<td><italic>N</italic>=108 HF patients<break/>Mean age 66 (range 63–71)<break/>HF diagnosis:</td>
<td>TMT-A<break/>TMT-B<break/>SCWI<break/>WAIS III<break/>Digit Span (forward and backward)<break/>Corsi Block Tapping<break/>RAVLT multiple<break/>Location Learning<break/>Rey Complex Figure<break/>SCWI</td>
<td>Worse levels of LV systolic function not associated with impairments in cognitive function<break/>Increased left ventricular mass index was associated with lower information processing speed (β = −0.102 (95% CI −0.195 to 0.008), <italic>p</italic>=&lt;0.05) and attention and processing speed (β = −0.121 (95% CI −0.217 to 0.026), <italic>p</italic>=&lt;0.05)</td>
</tr>
<tr>
<td><italic>Netherlands</italic></td>
<td/>
<td>systolic and diastolic HF using<break/>echocardiogram</td>
<td>Brixton Spatial Anticipation Test<break/>Letter Fluency<break/>Category Fluency<break/><italic>Scores adjusted for age, sex, and IQ</italic></td>
<td/></tr>
<tr>
<td>Vogels et al. (2007)<sup><xref ref-type="bibr" rid="bibr41-1474515112470046">41</xref></sup><break/><italic>Level of evidence: IV</italic><break/><italic>Netherlands</italic></td>
<td>Cross sectional case-control</td>
<td><italic>N</italic>=62 elders<break/><italic>N</italic>=53 age-matched cardiac controls<break/><italic>N</italic>=42 healthy controls<break/>Mean age 67.2–69.2<break/>HF diagnosis:<break/>systolic HF using<break/>echocardiogram</td>
<td>MMSE<break/>RAVLT<break/>Digit Span<break/>Pattern Recognition Memory<break/>Intra-Extra Dimensional Set Shift<break/>Stockings of Cambridge<break/>TMT-A<break/>TMT-B<break/>Fragmented Line Drawings<break/>Letter Fluency<break/>Categorical Fluency<break/>SCWI<break/><italic>Scores adjusted for age, sex, and IQ</italic></td>
<td>Lower executive function (<italic>M z</italic>-score −0.19±0.71, <italic>p</italic>=0.004), language (<italic>M</italic> z-score −0.18 ± 0.74, <italic>p</italic>=0.02), mental speed (<italic>M z</italic>-score −0.19±0.70, <italic>p</italic>=0.01) and overall cognitive function (<italic>M z</italic>-score −0.21±0.57, <italic>p</italic>=0.001) in patients with HF<break/>Lower scores in memory (<italic>p</italic>=0.02) and mental speed (<italic>p</italic>=0.01) in HF groups compared with cardiac controls<break/>LVEF not significantly associated with worse overall cognition (<italic>p</italic>=0.07)</td>
</tr>
<tr>
<td>Wolfe et al. (2006)<sup><xref ref-type="bibr" rid="bibr42-1474515112470046">42</xref></sup><break/><italic>Level of evidence: IV</italic><break/><italic>Australia</italic></td>
<td>Cross-sectional case-control</td>
<td><italic>N</italic>=38 HF patients recruited from hospitals in Australia<break/>Mean age 64 (range 47–75)<break/>HF diagnosis:<break/>systolic HF using clinical diagnosis and echocardiogram</td>
<td>Wechsler Abbreviated Scale of Intelligence<break/>Schonell Graded Word Reading Test<break/>RBANS<break/>Wisconsin Card Sorting Test<break/><italic>Scores not adjusted for age, sex, and IQ</italic></td>
<td>No significant relationship between EF and neurocognitive function (statistical data on this variable not reported)</td>
</tr>
<tr>
<td>Zuccalà et al. (1997)<sup><xref ref-type="bibr" rid="bibr32-1474515112470046">32</xref></sup><break/><italic>Level of evidence: VI</italic><break/><italic>Italy</italic></td>
<td>Cross-sectional descriptive</td>
<td><italic>N</italic>=57 HF patients<break/>Mean age 77<break/>HF diagnosis:<break/>systolic HF using<break/>echocardiogram and clinical criteria</td>
<td>MMSE<break/><italic>Effect of age and sex included in analysis</italic></td>
<td>Lower LVEF associated with lower MMSE scores (<italic>r</italic>=0.38, <italic>p</italic>=0.007)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1474515112470046">
<p>BNT: Boston Naming Test; CI: confidence interval; COWA: Controlled Oral Word Association; EF: ejection fraction; HF: heart failure; HVLT: Hopkins Verbal Learning Test; MMSE: Mini Mental State Exam; OR: odds ratio; RAVLT: Rey Auditory Verbal Learning Test; RBANS: Repeatable Battery for the Assessment of Neuropsychological Status; SCWI: Stroop Color Word Interference; TMT: Trail Making Test; WAIS: Wechsler Adult Intelligence Scale; WMS: Wechsler Memory Scale; CAMDEX: Cambridge Mental Disorders of the Elderly Examination; CAMCOG: Cambridge Cognitive Examination</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Zuccalà and colleagues were among the first to investigate the relationship between EF and cognitive impairment.<sup><xref ref-type="bibr" rid="bibr32-1474515112470046">32</xref></sup> In a small study (<italic>n</italic>=57), patients underwent an extensive physical assessment. Cognitive status was assessed using the Mini Mental Status Exam (MMSE). MMSE scores &lt;24 indicate impairment.<sup><xref ref-type="bibr" rid="bibr33-1474515112470046">33</xref></sup> A non-linear relationship between MMSE and HF was identified with patients having a low EF (≤ 30%) scoring significantly lower on the MMSE. Multivariate linear regression provided evidence of a strong correlation between the natural log of EF and MMSE scores (β=0.58, <italic>p</italic>=0.001). Although the association was significant, the study was limited by the small sample and use of a global assessment of cognition. The MMSE is reported to be inadequate in assessing mild cognitive impairment and does not evaluate executive function effectively.<sup><xref ref-type="bibr" rid="bibr6-1474515112470046">6</xref>,<xref ref-type="bibr" rid="bibr34-1474515112470046">34</xref>,<xref ref-type="bibr" rid="bibr35-1474515112470046">35</xref></sup></p>
<p>Additional studies (<italic>n</italic>=15) using neurocognitive batteries support a relationship between EF and cognitive impairment,<sup><xref ref-type="bibr" rid="bibr4-1474515112470046">4</xref>,<xref ref-type="bibr" rid="bibr17-1474515112470046">17</xref>,<xref ref-type="bibr" rid="bibr19-1474515112470046">19</xref><xref ref-type="bibr" rid="bibr20-1474515112470046"/><xref ref-type="bibr" rid="bibr21-1474515112470046"/><xref ref-type="bibr" rid="bibr22-1474515112470046"/><xref ref-type="bibr" rid="bibr23-1474515112470046"/><xref ref-type="bibr" rid="bibr24-1474515112470046"/><xref ref-type="bibr" rid="bibr25-1474515112470046"/><xref ref-type="bibr" rid="bibr26-1474515112470046"/><xref ref-type="bibr" rid="bibr27-1474515112470046"/><xref ref-type="bibr" rid="bibr28-1474515112470046"/><xref ref-type="bibr" rid="bibr29-1474515112470046"/><xref ref-type="bibr" rid="bibr30-1474515112470046"/>-<xref ref-type="bibr" rid="bibr31-1474515112470046">31</xref></sup> whereas seven refute it.<sup><xref ref-type="bibr" rid="bibr36-1474515112470046">36</xref><xref ref-type="bibr" rid="bibr37-1474515112470046"/><xref ref-type="bibr" rid="bibr38-1474515112470046"/><xref ref-type="bibr" rid="bibr39-1474515112470046"/><xref ref-type="bibr" rid="bibr40-1474515112470046"/><xref ref-type="bibr" rid="bibr41-1474515112470046"/>-<xref ref-type="bibr" rid="bibr42-1474515112470046">42</xref></sup> The largest study (<italic>n</italic>=1114) divided participants into five quintiles, based upon EF, with the lowest quintile having an EF &lt;62%.<sup><xref ref-type="bibr" rid="bibr27-1474515112470046">27</xref></sup> Participants in the lowest quintile had statistically lower scores in the domains of memory (<italic>p</italic>&lt;0.001) and visuoperception (<italic>p</italic>&lt;0.001). Within the lowest quintile, 18% (<italic>n</italic>=41) had an EF &lt;55%. Interestingly, individuals in the highest quintile, those with an EF &gt; 73.19%, demonstrated statistically lower scores on memory tests (Logical Memory Delayed Recall <italic>p</italic>=0.031, Visual Reproduction Delayed Recall <italic>p</italic>=0.029), executive functioning (<italic>p</italic>=0.022) and visuoperception (<italic>p</italic>=0.015). This is the only study to date that provided evidence of a non-linear, U-shaped relationship between EF and cognition.<sup><xref ref-type="bibr" rid="bibr27-1474515112470046">27</xref></sup> Of the seven studies refuting a relationship between EF and cognition,<sup><xref ref-type="bibr" rid="bibr36-1474515112470046">36</xref><xref ref-type="bibr" rid="bibr37-1474515112470046"/><xref ref-type="bibr" rid="bibr38-1474515112470046"/><xref ref-type="bibr" rid="bibr39-1474515112470046"/><xref ref-type="bibr" rid="bibr40-1474515112470046"/><xref ref-type="bibr" rid="bibr41-1474515112470046"/>-<xref ref-type="bibr" rid="bibr42-1474515112470046">42</xref></sup> the largest study (<italic>n</italic>=157)<sup><xref ref-type="bibr" rid="bibr41-1474515112470046">41</xref></sup> reported a trend toward a significant relationship (<italic>p</italic>=0.07).</p>
<p>Although supportive of our hypothesis of the relationship between EF and cognitive function, these studies have limitations. Sample size, sex and racial diversity varied greatly. Twelve studies were small, with samples of 100 or fewer participants.<sup><xref ref-type="bibr" rid="bibr4-1474515112470046">4</xref>,<xref ref-type="bibr" rid="bibr19-1474515112470046">19</xref>,<xref ref-type="bibr" rid="bibr21-1474515112470046">21</xref>,<xref ref-type="bibr" rid="bibr22-1474515112470046">22</xref>,<xref ref-type="bibr" rid="bibr25-1474515112470046">25</xref>,<xref ref-type="bibr" rid="bibr26-1474515112470046">26</xref>,<xref ref-type="bibr" rid="bibr28-1474515112470046">28</xref>,<xref ref-type="bibr" rid="bibr31-1474515112470046">31</xref>,<xref ref-type="bibr" rid="bibr32-1474515112470046">32</xref>,<xref ref-type="bibr" rid="bibr37-1474515112470046">37</xref>,<xref ref-type="bibr" rid="bibr38-1474515112470046">38</xref>,<xref ref-type="bibr" rid="bibr42-1474515112470046">42</xref></sup> The mean age ranged from 49.2 to 77 years and most studies (<italic>n</italic>=15) were predominantly male (63%–93%).<sup><xref ref-type="bibr" rid="bibr4-1474515112470046">4</xref>,<xref ref-type="bibr" rid="bibr17-1474515112470046">17</xref>,<xref ref-type="bibr" rid="bibr20-1474515112470046">20</xref><xref ref-type="bibr" rid="bibr21-1474515112470046"/><xref ref-type="bibr" rid="bibr22-1474515112470046"/><xref ref-type="bibr" rid="bibr23-1474515112470046"/>-<xref ref-type="bibr" rid="bibr24-1474515112470046">24</xref>,<xref ref-type="bibr" rid="bibr26-1474515112470046">26</xref>,<xref ref-type="bibr" rid="bibr29-1474515112470046">29</xref><xref ref-type="bibr" rid="bibr30-1474515112470046"/>-<xref ref-type="bibr" rid="bibr31-1474515112470046">31</xref>,<xref ref-type="bibr" rid="bibr36-1474515112470046">36</xref>,<xref ref-type="bibr" rid="bibr39-1474515112470046">39</xref>,<xref ref-type="bibr" rid="bibr42-1474515112470046">42</xref>,<xref ref-type="bibr" rid="bibr43-1474515112470046">43</xref></sup> Finally, racial diversity was sparsely reported likely due to the geographic origin of some studies. Countries of origin for each study are noted in <xref ref-type="table" rid="table3-1474515112470046">Tables 3</xref><xref ref-type="table" rid="table4-1474515112470046"/><xref ref-type="table" rid="table5-1474515112470046"/><xref ref-type="table" rid="table6-1474515112470046"/><xref ref-type="table" rid="table7-1474515112470046"/> to <xref ref-type="table" rid="table8-1474515112470046">8</xref>. Studies including racial statistics were predominantly Caucasian (60%–87%).<sup><xref ref-type="bibr" rid="bibr21-1474515112470046">21</xref><xref ref-type="bibr" rid="bibr22-1474515112470046"/><xref ref-type="bibr" rid="bibr23-1474515112470046"/>-<xref ref-type="bibr" rid="bibr24-1474515112470046">24</xref>,<xref ref-type="bibr" rid="bibr28-1474515112470046">28</xref>,<xref ref-type="bibr" rid="bibr30-1474515112470046">30</xref>,<xref ref-type="bibr" rid="bibr38-1474515112470046">38</xref></sup> Therefore, generalizability of these studies is limited.</p>
</sec>
<sec id="section9-1474515112470046">
<title>Cognition and BP</title>
<p>Variations in BP differentially affect both the survival and cognitive status of HF patients when compared with other cardiovascular diseases or healthy persons.<sup><xref ref-type="bibr" rid="bibr44-1474515112470046">44</xref><xref ref-type="bibr" rid="bibr45-1474515112470046"/>-<xref ref-type="bibr" rid="bibr46-1474515112470046">46</xref></sup> Typically, elevated systolic pressure is associated with increased cardiovascular risk (e.g. stroke).<sup><xref ref-type="bibr" rid="bibr47-1474515112470046">47</xref></sup> However, among patients with HF, lower systolic pressure is reportedly associated with decreased survival.<sup><xref ref-type="bibr" rid="bibr44-1474515112470046">44</xref>,<xref ref-type="bibr" rid="bibr46-1474515112470046">46</xref>,<xref ref-type="bibr" rid="bibr48-1474515112470046">48</xref></sup> Furthermore, among patients with HF, studies suggest that lower systolic pressure increases risk of cognitive impairment.<sup><xref ref-type="bibr" rid="bibr49-1474515112470046">49</xref><xref ref-type="bibr" rid="bibr50-1474515112470046"/><xref ref-type="bibr" rid="bibr51-1474515112470046"/>-<xref ref-type="bibr" rid="bibr52-1474515112470046">52</xref></sup> Several explanations for cognitive deficits among HF patients have been suggested. Cerebral hypoperfusion, chronic hypotension and excessive hypertension treatment are a few explanations related to BP in this population.<sup><xref ref-type="bibr" rid="bibr5-1474515112470046">5</xref>,<xref ref-type="bibr" rid="bibr50-1474515112470046">50</xref></sup></p>
<p>Lower systolic pressure has garnered the most empirical support in relation to cognitive impairment among HF patients compared with other objective metrics. Eight studies examining BP in relation to cognition were identified (<xref ref-type="table" rid="table4-1474515112470046">Table 4</xref>).<sup><xref ref-type="bibr" rid="bibr39-1474515112470046">39</xref>,<xref ref-type="bibr" rid="bibr49-1474515112470046">49</xref><xref ref-type="bibr" rid="bibr50-1474515112470046"/><xref ref-type="bibr" rid="bibr51-1474515112470046"/><xref ref-type="bibr" rid="bibr52-1474515112470046"/><xref ref-type="bibr" rid="bibr53-1474515112470046"/><xref ref-type="bibr" rid="bibr54-1474515112470046"/>-<xref ref-type="bibr" rid="bibr55-1474515112470046">55</xref></sup> Cognitive impairment was associated with lower systolic BP in four studies.<sup><xref ref-type="bibr" rid="bibr49-1474515112470046">49</xref>,<xref ref-type="bibr" rid="bibr51-1474515112470046">51</xref><xref ref-type="bibr" rid="bibr52-1474515112470046"/>-<xref ref-type="bibr" rid="bibr53-1474515112470046">53</xref></sup> Using a cut off systolic pressure of &lt; 130, Zuccalà et al. reported systolic BP was associated with cognitive impairment in 26% of HF patients versus 19% in the rest of the sample (<italic>n</italic>=1583 HF patients and <italic>n</italic>=12,052 patients without HF).<sup><xref ref-type="bibr" rid="bibr52-1474515112470046">52</xref></sup> In a subsequent study examining correlates of cognitive impairment in hospitalized patients (<italic>n</italic>=1511), 35% of HF patients were cognitively impaired versus 29% of others.<sup><xref ref-type="bibr" rid="bibr51-1474515112470046">51</xref></sup> Cognitive impairment was associated with lower BP, increased comorbidity burden, anemia, abnormal electrolytes, hyperglycemia and hypoalbuminemia. The investigators used a brief screening tool reported to be reliable in detecting mild cognitive impairment in these two studies. Another study reported similar findings with lower systolic pressure correlated with HF but only in patients scoring below the MMSE cut off (&lt;24).<sup><xref ref-type="bibr" rid="bibr49-1474515112470046">49</xref></sup> That is, although the MMSE is a global cognitive measure, lower BP may be useful to characterize cognitively impaired HF patients.</p>
<table-wrap id="table4-1474515112470046" position="float">
<label>Table 4.</label>
<caption>
<p>Cognition and BP.</p>
</caption>
<graphic alternate-form-of="table4-1474515112470046" xlink:href="10.1177_1474515112470046-table4.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Study</th>
<th align="left">Design</th>
<th align="left">Sample</th>
<th align="left">Cognitive measures</th>
<th align="left">Summary of results</th>
</tr>
</thead>
<tbody>
<tr>
<td>Cacciatore et al. (1998)<sup><xref ref-type="bibr" rid="bibr49-1474515112470046">49</xref></sup><break/><italic>Level of evidence: VI</italic><break/><italic>Italy</italic></td>
<td>Descriptive cross sectional</td>
<td><italic>N</italic>=1075<break/>Mean age 73.9<break/>HF diagnosis:<break/>clinical criteria or self-report</td>
<td>MMSE<break/><italic>Scores adjusted for age and education in analysis</italic></td>
<td>Systolic BP reduction negatively correlated with CHF only in subjects with MMSE score &lt; 24<break/>(<italic>r</italic>= −0.98, <italic>p</italic>=&lt;0.02)<break/>Diastolic BP not associated with MMSE at any score</td>
</tr>
<tr>
<td>Guo et al. (1997)<sup><xref ref-type="bibr" rid="bibr53-1474515112470046">53</xref></sup><break/><italic>Level of evidence: VI</italic><break/><italic>Sweden</italic></td>
<td>Cross-sectional</td>
<td><italic>N</italic>=1389 elders<break/>(<italic>n</italic>=280 HF patients)<break/>Mean age 85<break/>HF diagnosis:<break/>self-report and diagnostic codes</td>
<td>MMSE<break/><italic>Effect of age and sex included in analysis</italic></td>
<td>Lower systolic BP (&lt;130 mmHg) related to cognitive impairment (OR 3.49, CI 2.39–5.10) and ADL limitation. HF significantly related to low systolic and diastolic BP.<break/>Lower diastolic BP (&lt;70 mmHg) related to ADL limitation and cognitive impairment<break/>Those with cognitive impairment were three times more likely to have low systolic BP and two times more likely to have low diastolic BP</td>
</tr>
<tr>
<td>Hajjar et al. (2009)<sup><xref ref-type="bibr" rid="bibr54-1474515112470046">54</xref></sup><break/><italic>Level of evidence: IV</italic><break/><italic>USA</italic></td>
<td>Cross-sectional</td>
<td><italic>N</italic>=580 community-dwelling elders (10% in low performance group had HF)<break/>Mean age 77.8<break/>HF diagnosis:<break/>self-report</td>
<td>HVLT – Revised<break/>TMT-A<break/>TMT-B<break/><italic>Scores adjusted for age, education and race</italic></td>
<td>A group of elderly individuals with a phenotype of slow gait speed, greater depressive symptoms and worse executive function exists<break/>Elevated systolic BP is associated with being a member of this group. Members of the group more likely to report history of stroke (<italic>p</italic>=0.005), HF (<italic>p</italic>=0.006), and diabetes (<italic>p</italic>=0.0002)</td>
</tr>
<tr>
<td>Qiu et al. (2006)<sup><xref ref-type="bibr" rid="bibr50-1474515112470046">50</xref></sup><break/><italic>Level of evidence: VI</italic><break/><italic>Sweden</italic></td>
<td>Longitudinal descriptive</td>
<td><italic>N</italic>=1301<break/><italic>n</italic>=205 had HF at baseline<break/>Mean age 81.2–83.3<break/>HF diagnosis:<break/>clinical criteria</td>
<td>MMSE<break/><italic>Effect of age, education and sex included in analysis</italic></td>
<td>HF and low diastolic BP additively increase risk for dementia and Alzheimer disease<break/>(HR 3.07; 95% CI 1.67–5.61)</td>
</tr>
<tr>
<td>Stanek et al. (2009)<sup><xref ref-type="bibr" rid="bibr39-1474515112470046">39</xref></sup><break/><italic>Level of evidence: VI</italic><break/><italic>USA</italic></td>
<td>Longitudinal descriptive</td>
<td><italic>N</italic>=75 older adults with cardiovascular disease<break/><italic>n</italic>=40 had HF at baseline<break/>Mean age 70 (range 53–84)<break/>HF diagnosis:<break/>clinical diagnosis or echocardiogram</td>
<td>Global Dementia Rating Scale (DRS)<break/><italic>Effect of age, education and sex included in analysis</italic></td>
<td>HF patients had improvement in DRS score over 12 months<break/>(<italic>t</italic>=−3.60, <italic>p</italic>=0.001; <italic>d</italic>=0.57)<break/>Higher diastolic pressure at baseline was associated with improvement in DRS at 12 months</td>
</tr>
<tr>
<td>Trojano et al. (2003)<sup><xref ref-type="bibr" rid="bibr55-1474515112470046">55</xref></sup><break/><italic>Level of evidence: VI</italic><break/><italic>Italy</italic></td>
<td>Cross-sectional descriptive</td>
<td><italic>N</italic>=159 elders with severe HF<break/><italic>N</italic>=149 with moderate HF<break/><italic>N</italic>=207 free of HF<break/>Mean age 75<break/>HF diagnosis:<break/>clinical criteria</td>
<td>MMSE<break/>Attentional Matrices<break/>Raven Colored Progressive Matrices<break/>Categorical verbal fluency<break/>Corsi’s Block Tapping<break/>Verbal Word Span<break/>RAVLT<break/><italic>Scores adjusted for age and education</italic></td>
<td>Elevated BP significantly and independently correlated with abnormal performance on neuropsychological tests for those in the severe HF group in logistic regression model.<break/>Hypertension (β=0.6303, OR 1.88 (CI 1.18–2.29), <italic>p</italic>=0.0082)</td>
</tr>
<tr>
<td>Zuccalà et al. (2001)<sup><xref ref-type="bibr" rid="bibr52-1474515112470046">52</xref></sup><break/><italic>Level of evidence: VI</italic><break/><italic>Italy</italic></td>
<td>Cross-sectional descriptive</td>
<td><italic>N</italic>=1583 HF patients<break/><italic>N</italic>=12052 without HF<break/>Mean age not reported<break/>HF diagnosis:<break/>clinical criteria</td>
<td>Hodkinson Abbreviated Mental Test<break/><italic>Effect of age and sex included in analysis</italic></td>
<td>Systolic BP &lt;130 mmHg predicted cognitive impairment only among participants with HF<break/>(OR 0.97 (95% CI 0.94–1.01), <italic>p</italic>=&lt;0.0001)</td>
</tr>
<tr>
<td>Zuccalà et al. (2005)<sup><xref ref-type="bibr" rid="bibr51-1474515112470046">51</xref></sup><break/><italic>Level of evidence: VI</italic><break/><italic>Italy</italic></td>
<td>Cross-sectional descriptive</td>
<td><italic>N</italic>=1511 HF patients<break/>Mean age not reported<break/>HF diagnosis:<break/>clinical criteria</td>
<td>Hodkinson Abbreviated Mental Test<break/><italic>Effect of age and sex included in analysis</italic></td>
<td>Cognitive impairment associated with lower BP<break/>(OR 0.78, 95% CI 0.48–1.24)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-1474515112470046">
<p>BP: blood pressure; CHF: chronic heart failure; CI: confidence interval; HF: heart failure; HR: hazard ratio; MMSE: Mini Mental State Exam; OR: odds ratio; ADL: Activities of Daily Living</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The preponderance of evidence supports a relationship between lower systolic BP and impaired cognition, but two investigators refute this position.<sup><xref ref-type="bibr" rid="bibr54-1474515112470046">54</xref>,<xref ref-type="bibr" rid="bibr55-1474515112470046">55</xref></sup> Both studies used neuropsychological batteries to assess cognition. Trojano et al. compared patients with moderate (<italic>n</italic>=149) and severe (<italic>n</italic>=159) HF with persons who were HF free (<italic>n</italic>=207).<sup><xref ref-type="bibr" rid="bibr55-1474515112470046">55</xref></sup> Abnormal cognitive performance on more than two cognitive tests (primarily attention and memory) was associated with severe HF, higher depression scores and hypertension. However, a clinical history of hypertension versus actual BP readings was reported. Hajjar et al. also reported elevated, not lower, systolic BP to be associated with a phenotype of worse cognition (executive function), slow gait speed and higher depression scores.<sup><xref ref-type="bibr" rid="bibr54-1474515112470046">54</xref></sup> The analysis accounted for variables known to affect cognition (e.g. age, education, gender). Interestingly, if the patient had HF, higher systolic pressure was <italic>not</italic> associated with the phenotype as described. Supporting differences in the effect of systolic pressure in the presence of HF, a small study (<italic>n</italic>=70) of healthy elders (e.g. excluded HF, other chronic illnesses) reported that elevated BP was associated with impaired executive function.<sup><xref ref-type="bibr" rid="bibr45-1474515112470046">45</xref></sup> Therefore, evidence suggests that specifically among HF patients, it is questionable whether higher systolic pressure and cognitive impairment are related.</p>
<p>Results were mixed in reports of diastolic BP and cognition. Two investigators concluded there was increased risk of cognitive impairment associated with lower diastolic BP.<sup><xref ref-type="bibr" rid="bibr50-1474515112470046">50</xref>,<xref ref-type="bibr" rid="bibr53-1474515112470046">53</xref></sup> Qiu et al. concluded that HF and lower diastolic BP were additive in increasing risk for dementia and Alzheimer’s Disease in HF patients.<sup><xref ref-type="bibr" rid="bibr50-1474515112470046">50</xref></sup> Guo et al. reported that both lower systolic (&lt;130) and lower diastolic BP (&lt;70) were significantly associated with HF, limitations in activities of daily living and cognitive impairment in univariate and multivariate analyses of 1389 patients in Sweden.<sup><xref ref-type="bibr" rid="bibr53-1474515112470046">53</xref></sup> Cognitively impaired patients were three times more likely to have lower systolic BP and twice as likely to have lower diastolic BP. However, the relationship between HF and lower diastolic BP did not persist in multivariate analysis. Both aforementioned studies used the MMSE to assess cognition. Conversely, another study reported that higher diastolic BP was associated with better cognition in HF patients in a small longitudinal study (<italic>n</italic>=75) evaluating cognition at baseline and 12 months.<sup><xref ref-type="bibr" rid="bibr39-1474515112470046">39</xref></sup> The authors suggest that cognitive function is modifiable in HF patients. They hypothesized that effective HF management (e.g. leading to better BP control) potentially explained the relationship. Cognition was assessed at 12 months, but BP was not. Therefore, their hypothesis is debatable. Overall, support for the relationship between lower diastolic pressure and cognitive impairment is limited.</p>
<p>Limits to generalizability include samples primarily of White males. Only one study reported ethnicity (80% White).<sup><xref ref-type="bibr" rid="bibr54-1474515112470046">54</xref></sup> All other studies were conducted in Italy or Sweden and ethnicity data was not provided. Sample size and representation of both genders was adequate. Sample size ranged from <italic>n</italic>=515 to <italic>n</italic>=1583 with four<sup><xref ref-type="bibr" rid="bibr49-1474515112470046">49</xref>,<xref ref-type="bibr" rid="bibr51-1474515112470046">51</xref>,<xref ref-type="bibr" rid="bibr52-1474515112470046">52</xref>,<xref ref-type="bibr" rid="bibr55-1474515112470046">55</xref></sup> of seven studies approximately 50% male. The mean age across studies was typically older (<italic>M</italic>=80 years) consistent with the HF population and ranged from 73.9 to 85 years. Overall, the relationship between lower systolic BP and cognitive impairment risk is persuasive.</p>
</sec>
<sec id="section10-1474515112470046">
<title>Cognition and functional status</title>
<p>Functional status is routinely assessed in HF patients to determine response to therapies and monitor disease progression. Common non-invasive methods for assessing function include the NYHA functional class and the six-minute walk test. In clinical practice, the four-point NYHA class based on symptom burden is frequently used. Class I reflects no symptoms with typical activity, ranging up to class IV, indicating symptoms at rest. Importantly, functional status as measured by NYHA functional class is predictive of quality of life and survival.<sup><xref ref-type="bibr" rid="bibr56-1474515112470046">56</xref><xref ref-type="bibr" rid="bibr57-1474515112470046"/><xref ref-type="bibr" rid="bibr58-1474515112470046"/>-<xref ref-type="bibr" rid="bibr59-1474515112470046">59</xref></sup> As cognitive impairment among HF patients is reportedly associated with symptom and disease severity,<sup><xref ref-type="bibr" rid="bibr60-1474515112470046">60</xref></sup> the literature was examined for the value of functional status in relation to cognitive impairment risk.</p>
<p>Worse cognitive function was associated with lower functional status in the majority of studies (11 of 15) reporting analyses of this relationship (<xref ref-type="table" rid="table5-1474515112470046">Table 5</xref>).<sup><xref ref-type="bibr" rid="bibr21-1474515112470046">21</xref>,<xref ref-type="bibr" rid="bibr22-1474515112470046">22</xref>,<xref ref-type="bibr" rid="bibr32-1474515112470046">32</xref>,<xref ref-type="bibr" rid="bibr34-1474515112470046">34</xref>,<xref ref-type="bibr" rid="bibr41-1474515112470046">41</xref>,<xref ref-type="bibr" rid="bibr55-1474515112470046">55</xref>,<xref ref-type="bibr" rid="bibr61-1474515112470046">61</xref><xref ref-type="bibr" rid="bibr62-1474515112470046"/><xref ref-type="bibr" rid="bibr63-1474515112470046"/><xref ref-type="bibr" rid="bibr64-1474515112470046"/>-<xref ref-type="bibr" rid="bibr65-1474515112470046">65</xref></sup> To assess cognitive function, cognitive batteries of varying depth were used in all but two studies.<sup><xref ref-type="bibr" rid="bibr32-1474515112470046">32</xref>,<xref ref-type="bibr" rid="bibr64-1474515112470046">64</xref></sup> Functional status was assessed using NYHA functional class,<sup><xref ref-type="bibr" rid="bibr22-1474515112470046">22</xref>,<xref ref-type="bibr" rid="bibr32-1474515112470046">32</xref>,<xref ref-type="bibr" rid="bibr34-1474515112470046">34</xref>,<xref ref-type="bibr" rid="bibr36-1474515112470046">36</xref><xref ref-type="bibr" rid="bibr37-1474515112470046"/>-<xref ref-type="bibr" rid="bibr38-1474515112470046">38</xref>,<xref ref-type="bibr" rid="bibr55-1474515112470046">55</xref>,<xref ref-type="bibr" rid="bibr63-1474515112470046">63</xref><xref ref-type="bibr" rid="bibr64-1474515112470046"/>-<xref ref-type="bibr" rid="bibr65-1474515112470046">65</xref></sup> timed walk tests<sup><xref ref-type="bibr" rid="bibr61-1474515112470046">61</xref><xref ref-type="bibr" rid="bibr62-1474515112470046"/>-<xref ref-type="bibr" rid="bibr63-1474515112470046">63</xref></sup> and the Duke Activity Scale Index.<sup><xref ref-type="bibr" rid="bibr15-1474515112470046">15</xref></sup> Although none of the studies were randomized trials, the five studies with the largest samples support an association between lower cognition and poorer functional status.<sup><xref ref-type="bibr" rid="bibr55-1474515112470046">55</xref>,<xref ref-type="bibr" rid="bibr61-1474515112470046">61</xref>,<xref ref-type="bibr" rid="bibr63-1474515112470046">63</xref><xref ref-type="bibr" rid="bibr64-1474515112470046"/>-<xref ref-type="bibr" rid="bibr65-1474515112470046">65</xref></sup></p>
<table-wrap id="table5-1474515112470046" position="float">
<label>Table 5.</label>
<caption>
<p>Cognition and functional status.</p>
</caption>
<graphic alternate-form-of="table5-1474515112470046" xlink:href="10.1177_1474515112470046-table5.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Study</th>
<th align="left">Design</th>
<th align="left">Sample</th>
<th align="left">Cognitive measures</th>
<th align="left">Summary of results</th>
</tr>
</thead>
<tbody>
<tr>
<td>Almeida et al. (2012)<sup><xref ref-type="bibr" rid="bibr36-1474515112470046">36</xref></sup><break/><italic>Level of evidence: IV</italic><break/><italic>Australia</italic></td>
<td>Longitudinal case control</td>
<td><italic>N</italic>=77 HF<break/><italic>N</italic>=73 heart disease<break/><italic>N</italic>=81 controls<break/>Mean age between groups 67.8 to 69.3 (range 45–86)<break/>HF diagnosis: EF &lt;40% by echocardiogram and symptoms of HF</td>
<td>MMSE<break/>CAMCOG<break/>California Verbal Learning Test<break/>Digit Copy<break/>Digit Coding<break/>WAIS<break/><italic>Scores adjusted for age, gender and IQ in analysis</italic></td>
<td>CAMCOG scores were lower in HF patients compared with controls (95% CI −1.7, −0.1; <italic>p</italic>=0.022)<break/>Adding the six minute walk test to the model weakened the association between HF and cognitive decline (95% CI −1.6, 0.1; <italic>p</italic>=0.073)</td>
</tr>
<tr>
<td>Alosco et al. (2011)<sup><xref ref-type="bibr" rid="bibr61-1474515112470046">61</xref></sup><break/><italic>Level of evidence: VI</italic><break/><italic>USA</italic></td>
<td>Prospective, cross-sectional descriptive</td>
<td><italic>N</italic>=145 elders with HF<break/>Mean age 68.9<break/>HF diagnosis:<break/>HF diagnosis using medical record</td>
<td>MMSE<break/>TMT-A<break/>TMT-B<break/>Digit Symbol<break/>Letter–Number Sequencing<break/>Frontal Assessment Battery<break/>SCWI<break/>California Verbal Learning Test<break/>BNT<break/>Animal Fluency<break/><italic>Effect of age and sex included in analysis</italic></td>
<td>Lower step count on two-minute step test (2MST) associated with decreased cognitive function (executive function (β=0.05, <italic>p</italic>=&lt;0.05), language (β=0.13,<break/><italic>p</italic>=&lt;0.001) and global cognition<break/>(β =0.08, <italic>p</italic>=&lt;0.001)</td>
</tr>
<tr>
<td>Beer et al. (2009)<sup><xref ref-type="bibr" rid="bibr62-1474515112470046">62</xref></sup><break/><italic>Level of evidence: IV</italic><break/><italic>Australia</italic></td>
<td>Case-control, correlational, cross sectional</td>
<td><italic>N</italic>=31 HF patients<break/><italic>N</italic>=24 controls<break/>Mean age 54.3–56.1<break/>HF diagnosis:<break/>systolic HF using<break/>echocardiogram</td>
<td>CAMDEX<break/>CAMCOG<break/><italic>Effect of age, sex, education and depression included in analysis</italic></td>
<td>HF patients had lower scores on CAMCOG, executive function, visual memory and verbal learning tasks than controls<break/>Correlation between six minute walk test performance and CAMCOG score indicates better cognition correlated with better function (<italic>r</italic>=0.42, <italic>p</italic>=&lt;0.05)</td>
</tr>
<tr>
<td>Callegari et al. (2002)<sup><xref ref-type="bibr" rid="bibr66-1474515112470046">66</xref></sup><break/><italic>Level of evidence: VI</italic><break/><italic>Italy</italic></td>
<td>Cross-sectional descriptive</td>
<td><italic>N</italic>=64 male HF outpatients with NYHA class I–III<break/>Mean age 51.8<break/>HF diagnosis: echocardiogram, cardiac catheterization</td>
<td>Verbal Span Test<break/>Corsi Block-Tapping<break/>Serial position curve<break/>Prose Memory Test<break/>Digit Cancellation Test<break/>Verbal Judgment Test<break/>Raven Progressive<break/>Matrices<break/>Token test<break/><italic>Effect of age, sex (all male sample), and education included in analysis</italic></td>
<td>HF patients had lower cognitive scores on memory and logical ability<break/>No statistically significant relationship between NYHA class and cognitive tests was reported</td>
</tr>
<tr>
<td>Dickson et al. (2008)<sup><xref ref-type="bibr" rid="bibr21-1474515112470046">21</xref></sup><break/><italic>Level of evidence: VI</italic></td>
<td>Cross-sectional/mixed methods</td>
<td><italic>N</italic>=41 HF patients from outpatient clinics<break/>Mean age 49.17 (range 25–65)</td>
<td>Digit Symbol<break/>Probed Memory Recall<break/>Letter–Number Sequencing</td>
<td>Cognition and Duke Activity Status Index were positively correlated (<italic>r</italic>=0.39, <italic>p</italic>=0.035) indicating better cognition as measured by probed memory recall, the better the function</td>
</tr>
<tr>
<td><italic>USA</italic></td>
<td/>
<td>HF diagnosis:<break/>systolic, diastolic and mixed class II or III HF by EF criteria</td>
<td><italic>Effect of age included in analysis</italic></td>
<td/></tr>
<tr>
<td>Dixit et al. (2010)<sup><xref ref-type="bibr" rid="bibr22-1474515112470046">22</xref></sup><break/><italic>Level of evidence: IV</italic><break/><italic>USA</italic></td>
<td>Quasi-experimental<break/>Pretest posttest<break/>(patient own control)</td>
<td><italic>N</italic>=20 patients undergoing placement of a biventricular pacing device for CRT<break/>Mean age 54.8<break/>HF diagnosis:<break/>systolic HF using echocardiogram</td>
<td>TMT-A<break/>TMT-B<break/>Digit Span<break/>Digit Symbol<break/>HVLT – Revised<break/>COWA<break/><italic>Scores adjusted for age and education</italic></td>
<td>Improvement in functional class three months post CRT implant.<break/>Improvement in cognition noted three months post implant:<break/>improvements in attention (Digit Span <italic>t</italic>= −2.695, <italic>p</italic>=0.015) and information processing (Digit Symbol <italic>t</italic>= −4.577, <italic>p</italic>&lt;0.001; COWA <italic>t</italic>= −3.338, <italic>p</italic>=0.004)</td>
</tr>
<tr>
<td>Gorkin et al. (1993)<sup><xref ref-type="bibr" rid="bibr63-1474515112470046">63</xref></sup><break/><italic>Level of evidence: VI</italic><break/><italic>USA</italic></td>
<td>Cross sectional descriptive</td>
<td><italic>N</italic>=308 HF patients<break/>Mean age 59.6–61.9<break/>HF diagnosis:<break/>systolic HF using EF criteria</td>
<td>Digit Span<break/>TMT-A<break/>TMT-B<break/><italic>Scores adjusted for age and education</italic></td>
<td>Poor cognitive status associated with NYHA class<break/>Poorer attention (Digit Span, TMT-A) <italic>p</italic>=0.01 and psychomotor speed (TMT-A) <italic>p</italic>=0.05 associated with NYHA class II and III compared with class I</td>
</tr>
<tr>
<td>Harkness et al. (2011)<sup><xref ref-type="bibr" rid="bibr34-1474515112470046">34</xref></sup><break/><italic>Level of evidence: VI</italic><break/><italic>Canada</italic></td>
<td>Cross-sectional descriptive</td>
<td><italic>N</italic>=44 elders with HF<break/>Mean age 76<break/>HF diagnosis:<break/>systolic HF using EF criteria</td>
<td>MoCA<break/><italic>Effect of age and sex included in analysis</italic></td>
<td>MoCA revealed cognitive impairment in &gt;70% of the sample<break/>91% of patients with higher NYHA class (III, IV) had lower MoCA scores</td>
</tr>
<tr>
<td>Kerola et al. (2010)<sup><xref ref-type="bibr" rid="bibr64-1474515112470046">64</xref></sup><break/><italic>Level of evidence: IV</italic><break/><italic>Finland</italic></td>
<td>Longitudinal descriptive cohort study</td>
<td><italic>N</italic>=303 community-dwelling elders<break/>(Highest BNP group −43% HF)<break/>Mean age 78.6–81.3<break/>HF diagnosis:<break/>HF diagnosis using medical record</td>
<td>MMSE<break/><italic>Effect of age, sex, and education included in analysis</italic></td>
<td>Higher NYHA class (III, IV) associated with lower MMSE at baseline (β= −0.177, <italic>p</italic>=&lt;0.001)</td>
</tr>
<tr>
<td>Mauro et al. (2007)<sup><xref ref-type="bibr" rid="bibr37-1474515112470046">37</xref></sup><break/><italic>Level of evidence: VI</italic><break/><italic>Italy</italic></td>
<td>Cross-sectional, descriptive</td>
<td><italic>N</italic>=60 HF patients<break/>Mean age 65.5 (range 24–87)<break/>HF diagnosis:<break/>systolic and diastolic HF using echocardiogram</td>
<td>MMSE<break/>Corsi Block Tapping<break/>Prose Memory Test<break/>Visual Search Test<break/><italic>Scores adjusted for age and education</italic></td>
<td>MMSE &lt; 24 (<italic>N</italic>=14 patients)<break/>No significant relationship between cognition and functional class (<italic>r</italic>=0.01, <italic>p</italic>=0.37)</td>
</tr>
<tr>
<td>Pressler et al. (2010)<sup><xref ref-type="bibr" rid="bibr65-1474515112470046">65</xref></sup><break/><italic>Level of evidence: IV</italic></td>
<td>Cross-sectional comparative</td>
<td>N=249 HF patients<break/><italic>N</italic>=102 medical controls<break/><italic>N</italic>=63 healthy controls</td>
<td>MMSE<break/>BNT<break/>Digit span<break/>Digit symbol</td>
<td>Greater HF severity (NYHA class) associated with decreased memory, visuospatial ability, psychomotor speed and executive function TMT-B (Class IV – β=3.74, <italic>p</italic>=&lt;0.001); COWA (Class IV – β=4.45, <italic>p</italic>=0.002)</td>
</tr>
<tr>
<td><italic>USA</italic></td>
<td/>
<td>Mean age 53.3–63<break/>HF diagnosis:<break/>systolic HF using echocardiogram, cardiac catheterization or nuclear imaging criteria</td>
<td>HVLT<break/>TMT-A<break/>TMT-B<break/>COWA<break/>Figure copy<break/>WAIS – Revised
<break/><italic>Effect of age, sex, premorbid intellect and education included in analysis</italic></td>
<td/></tr>
<tr>
<td>Sauve et al. (2009)<sup><xref ref-type="bibr" rid="bibr38-1474515112470046">38</xref></sup><break/><italic>Level of evidence: IV</italic><break/><italic>USA</italic></td>
<td>Case-control</td>
<td><italic>N</italic>=50 patients with HF with mean EF of 27%<break/><italic>N</italic>=50 age, gender, IQ matched controls<break/>Mean age 63 and 62.5 for HF patients and controls respectively<break/>HF diagnosis:<break/>cardiac catheterization and echocardiogram</td>
<td>Neurobehavioral Cognitive Status Exam<break/>Symbol Digit<break/>Rey Auditory Verbal Learning Test<break/>COWA<break/>Finger Tapping Test<break/>Memory Scanning Test<break/>Visual Scanning Test<break/>WAIS – Revised<break/>Vocabulary<break/><italic>Effect of age, IQ and sex included in analysis</italic></td>
<td>Cognitive impairment identified in 46% of HF patients compared with 16% in the controls<break/>HF correlated with cognitive impairment (OR 4.47, 95% CI 1.75, 11.43; <italic>p</italic> ≤ 0.002)<break/>NYHA class not associated with severity of cognitive impairment</td>
</tr>
<tr>
<td>Trojano et al. (2003)<sup><xref ref-type="bibr" rid="bibr55-1474515112470046">55</xref></sup><break/><italic>Level of evidence: VI</italic><break/><italic>Italy</italic></td>
<td>Cross-sectional descriptive</td>
<td><italic>N</italic>=159 elders with severe HF<break/><italic>N</italic>=149 with moderate HF<break/><italic>N</italic>=207 free of HF<break/>Mean age 75<break/>HF diagnosis:<break/>clinical criteria</td>
<td>MMSE<break/>Attentional Matrices<break/>Raven Colored Progressive Matrices<break/>Categorical verbal fluency<break/>Corsi’s Block Tapping<break/>Verbal Word Span<break/>RAVLT<break/><italic>Scores adjusted for age and education</italic></td>
<td>NYHA III and IV had significantly worse cognitive function, primarily in attention and memory, than patients without HF. Severe HF was independent correlate of abnormal performance on at least three cognitive tests in logistic regression analysis (β=0.9412, OR 2.56 (95% CI 1.49–4.40), <italic>p</italic>=0.0006)</td>
</tr>
<tr>
<td>Vogels et al. (2007)<sup><xref ref-type="bibr" rid="bibr41-1474515112470046">41</xref></sup><break/><italic>Level of evidence: IV</italic><break/><italic>Netherlands</italic></td>
<td>Cross sectional case-control</td>
<td><italic>N</italic>=62 elders<break/><italic>N</italic>=53 age-matched cardiac controls<break/><italic>N</italic>=42 healthy controls<break/>Mean age 67.2–69.2<break/>HF diagnosis:<break/>systolic HF using echocardiogram</td>
<td>MMSE<break/>RAVLT<break/>Digit Span<break/>Pattern Recognition Memory<break/>Intra-Extra Dimensional Set Shift<break/>Stockings of Cambridge<break/>TMT-A<break/>TMT-B<break/>Fragmented Line Drawings<break/>Letter Fluency<break/>Categorical Fluency<break/>SCWI<break/><italic>Scores adjusted for age, sex, and IQ</italic></td>
<td>Lower executive function, language, mental speed and overall cognitive function in patients with HF<break/>Lower scores in memory and mental speed in HF groups compared with cardiac controls<break/>NYHA class independent predictor of worse cognitive performance in HF patients and cardiac controls (β= −0.237, <italic>p</italic>=&lt;0.01)</td>
</tr>
<tr>
<td>Zuccalà et al. (1997)<sup><xref ref-type="bibr" rid="bibr32-1474515112470046">32</xref></sup><break/><italic>Level of evidence: VI</italic><break/><italic>Italy</italic></td>
<td>Cross-sectional descriptive</td>
<td><italic>N</italic>=57 HF patients<break/>Mean age 77<break/>HF diagnosis:<break/>systolic HF using echocardiogram/clinical criteria</td>
<td>MMSE<break/><italic>Effect of age and sex included in analysis</italic></td>
<td>Increased HF severity (NYHA class) associated with lower MMSE scores (<italic>r</italic>= −0.51, <italic>p</italic>=0.001)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-1474515112470046">
<p>BNP: B natriuretic peptide; CI: confidence interval; COWA: Controlled Oral Word Association; EF: ejection fraction; HF: heart failure; HVLT: Hopkins Verbal Learning Test; MMSE: Mini Mental State Exam; MoCA: Montreal Cognitive Assessment; NYHA: New York Heart Association; OR: odds ratio; SCWI: Stroop Color Word Interference; TMT: Trail Making Test; CAMCOG: Cambridge Cognitive Examination</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Cognitive status may be confounded by several factors, including age, education, intelligence, depression and other chronic conditions. Appropriately, Trojano and colleagues<sup><xref ref-type="bibr" rid="bibr55-1474515112470046">55</xref></sup> accounted for several risk factors for cognitive impairment in a study comparing patients with moderate (<italic>n</italic>=149) and severe (<italic>n</italic>=159) HF with patients without HF (<italic>n</italic>=207). Higher NYHA class was linked to cognitive impairment with attention and memory domains mainly affected. In addition, cognitive impairment was more prevalent in those with two or more risk factors. Similar findings were reported by Pressler in a study comparing cognitive function between HF patients (<italic>n</italic>=249) and healthy (<italic>n</italic>=63) and medical participants (<italic>n</italic>=102).<sup><xref ref-type="bibr" rid="bibr65-1474515112470046">65</xref></sup> HF patients had poorer memory, psychomotor speed and executive function. Furthermore, HF severity as assessed by NYHA class was associated with memory, visuospatial ability, psychomotor speed and executive function. Age coupled with function was a factor as well. Older patients with more severe HF had poorer executive function. Using a two minute step test as a measure of function (<italic>n</italic>=145 HF patients), Alosco and colleagues reported a significant relationship between executive function and language.<sup><xref ref-type="bibr" rid="bibr61-1474515112470046">61</xref></sup> Similar to the work of Pressler and Trojano, several confounding variables were included in the analysis. In the Studies of Left Ventricular Dysfunction (SOLVD), higher NYHA class was associated only with slower psychomotor speed.<sup><xref ref-type="bibr" rid="bibr63-1474515112470046">63</xref></sup> Four studies refuted the relationship between cognition and functional status.<sup><xref ref-type="bibr" rid="bibr36-1474515112470046">36</xref><xref ref-type="bibr" rid="bibr37-1474515112470046"/>-<xref ref-type="bibr" rid="bibr38-1474515112470046">38</xref>,<xref ref-type="bibr" rid="bibr66-1474515112470046">66</xref></sup> Sauve conducted a case control study with 50 HF patients matched on age, IQ and gender with 50 community participants.<sup><xref ref-type="bibr" rid="bibr38-1474515112470046">38</xref></sup> Although severity of cognitive impairment and NYHA class was not statistically significant for the sample as a whole, the <italic>p</italic> value approached significance (<italic>p</italic>≤ 0.08). Furthermore, for NYHA class III/IV participants, NYHA class was associated with poorer learning curves and impairment of attention (<italic>p</italic>&lt; 0.001) and memory (<italic>p</italic>&lt; 0.001). In another small study (<italic>N</italic>=60) refuting a relationship between cognition and functional status (<italic>r</italic>=0.01, <italic>p</italic>=0.37)<sup><xref ref-type="bibr" rid="bibr37-1474515112470046">37</xref></sup> only 23.3% of participants had a MMSE≤ 24 despite a relatively low educational level in the sample. Therefore, the study potentially was underpowered for detecting a relationship between cognition and functional status. Finally, a study which excluded NYHA class IV patients and was limited to males (<italic>N</italic>=64) also reported no relationship between function and cognition.<sup><xref ref-type="bibr" rid="bibr66-1474515112470046">66</xref></sup> Overall, the literature to date supports the relationship of poor cognitive function and lower functional status.<sup><xref ref-type="bibr" rid="bibr21-1474515112470046">21</xref>,<xref ref-type="bibr" rid="bibr22-1474515112470046">22</xref>,<xref ref-type="bibr" rid="bibr32-1474515112470046">32</xref>,<xref ref-type="bibr" rid="bibr34-1474515112470046">34</xref>,<xref ref-type="bibr" rid="bibr41-1474515112470046">41</xref>,<xref ref-type="bibr" rid="bibr55-1474515112470046">55</xref>,<xref ref-type="bibr" rid="bibr61-1474515112470046">61</xref><xref ref-type="bibr" rid="bibr62-1474515112470046"/><xref ref-type="bibr" rid="bibr63-1474515112470046"/><xref ref-type="bibr" rid="bibr64-1474515112470046"/>-<xref ref-type="bibr" rid="bibr65-1474515112470046">65</xref></sup></p>
<p>Limits to generalizability include samples of primarily samples of white males. Of the 15 studies reporting on functional status and cognitive impairment, only those conducted in the United States reported ethnicity ranging 67 to 97.4% white.<sup><xref ref-type="bibr" rid="bibr21-1474515112470046">21</xref>,<xref ref-type="bibr" rid="bibr22-1474515112470046">22</xref>,<xref ref-type="bibr" rid="bibr38-1474515112470046">38</xref>,<xref ref-type="bibr" rid="bibr61-1474515112470046">61</xref>,<xref ref-type="bibr" rid="bibr63-1474515112470046">63</xref>,<xref ref-type="bibr" rid="bibr65-1474515112470046">65</xref></sup> Six studies had small samples ranging from 20 to 60 participants.<sup><xref ref-type="bibr" rid="bibr21-1474515112470046">21</xref>,<xref ref-type="bibr" rid="bibr22-1474515112470046">22</xref>,<xref ref-type="bibr" rid="bibr32-1474515112470046">32</xref>,<xref ref-type="bibr" rid="bibr34-1474515112470046">34</xref>,<xref ref-type="bibr" rid="bibr37-1474515112470046">37</xref>,<xref ref-type="bibr" rid="bibr62-1474515112470046">62</xref></sup> Most studies had slightly more male participants than female (average 62%)<sup><xref ref-type="bibr" rid="bibr21-1474515112470046">21</xref>,<xref ref-type="bibr" rid="bibr22-1474515112470046">22</xref>,<xref ref-type="bibr" rid="bibr37-1474515112470046">37</xref>,<xref ref-type="bibr" rid="bibr41-1474515112470046">41</xref>,<xref ref-type="bibr" rid="bibr61-1474515112470046">61</xref>,<xref ref-type="bibr" rid="bibr63-1474515112470046">63</xref>,<xref ref-type="bibr" rid="bibr65-1474515112470046">65</xref>,<xref ref-type="bibr" rid="bibr66-1474515112470046">66</xref></sup> with a mean age across studies of 63.8 ranging from 49.2 to 77 years. Despite these limitations, the studies with the largest sample sizes support the relationship between poor cognitive function and lower functional status.<sup><xref ref-type="bibr" rid="bibr41-1474515112470046">41</xref>,<xref ref-type="bibr" rid="bibr55-1474515112470046">55</xref>,<xref ref-type="bibr" rid="bibr61-1474515112470046">61</xref>,<xref ref-type="bibr" rid="bibr63-1474515112470046">63</xref>,<xref ref-type="bibr" rid="bibr65-1474515112470046">65</xref></sup></p>
</sec>
<sec id="section11-1474515112470046">
<title>Cognition and HF-related laboratory tests</title>
<p>Congruent with the purpose of this review, laboratory tests routinely evaluated in hospitalized HF patients were examined in relation to cognition. Tests most commonly reported include BNP, tests of renal function and lipids. If evidence exists supporting the association of cognitive impairment with a laboratory test that is regularly monitored as part of standard HF treatment, identification of individuals at risk for mild cognitive impairment would be simplified.</p>
<p>BNP is a neurohormone released by the heart in relation to elevated intracardiac pressures or volumes. BNP is recommended in clinical guidelines to monitor severity of HF.<sup><xref ref-type="bibr" rid="bibr67-1474515112470046">67</xref></sup> Recent evidence suggests that pro-BNP, a precursor to BNP, may be a more reliable marker for HF.<sup><xref ref-type="bibr" rid="bibr68-1474515112470046">68</xref>,<xref ref-type="bibr" rid="bibr69-1474515112470046">69</xref></sup> As a result, some clinicians are not routinely evaluating BNP. There are studies which deemphasize this relationship, however.<sup><xref ref-type="bibr" rid="bibr70-1474515112470046">70</xref></sup> Though not extensive, evidence to date supports the relationship between BNP and cognitive impairment (<xref ref-type="table" rid="table6-1474515112470046">Table 6</xref>). Three studies looked at the relationship between these variables.<sup><xref ref-type="bibr" rid="bibr40-1474515112470046">40</xref>,<xref ref-type="bibr" rid="bibr43-1474515112470046">43</xref>,<xref ref-type="bibr" rid="bibr64-1474515112470046">64</xref></sup> Two studies used the MMSE to evaluate global cognitive function and reported that elevated BNP levels were associated with lower scores.<sup><xref ref-type="bibr" rid="bibr43-1474515112470046">43</xref>,<xref ref-type="bibr" rid="bibr64-1474515112470046">64</xref></sup> Kerola used the MMSE as the only measure of cognitive function in a five-year study of a cohort of 303 dementia-free patients. Participants were divided into tertiles based on BNP levels. Forty-three percent of participants with the highest BNPs at baseline had HF. Regression analysis revealed a negative relationship between MMSE score and BNP level (β= −0.151, <italic>p</italic>=0.001) with higher BNP levels associated with lower MMSE. Furthermore, an elevated BNP was predictive of MMSE decline over time (β=0.14, <italic>p</italic>=0.019).<sup><xref ref-type="bibr" rid="bibr64-1474515112470046">64</xref></sup> In addition to the MMSE, Mauro added a small neuropsychological battery, assessing memory and attention, specifically.37 Although a correlation between MMSE and BNP (<italic>r</italic>=0.25, <italic>p</italic>=0.02) was identified, there was no relationship between BNP and the specific domains evaluated in this small sample (<italic>n</italic>=60). The largest study reviewed (<italic>n</italic>=313) evaluated specific cognitive domains and reported that elevated baseline BNP levels predicted lower scores for information processing speed (β= −0.158, <italic>p</italic>&lt;0.05), memory (β= −0.165, <italic>p</italic>&lt;0.05), attention and executive functioning (β= −0.279, <italic>p</italic>&lt;0.05).<sup><xref ref-type="bibr" rid="bibr40-1474515112470046">40</xref></sup> Overall, the studies of BNP provide limited support for BNP as a marker for mild cognitive impairment risk.</p>
<table-wrap id="table6-1474515112470046" position="float">
<label>Table 6.</label>
<caption>
<p>Cognition and B-type natriuretic peptide.</p>
</caption>
<graphic alternate-form-of="table6-1474515112470046" xlink:href="10.1177_1474515112470046-table6.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Study</th>
<th align="left">Design</th>
<th align="left">Sample</th>
<th align="left">Cognitive measures</th>
<th align="left">Summary of results</th>
</tr>
</thead>
<tbody>
<tr>
<td>Kerola et al. (2010)<sup><xref ref-type="bibr" rid="bibr64-1474515112470046">64</xref></sup><break/><italic>Level of evidence: IV</italic><break/><italic>Finland</italic></td>
<td>Longitudinal descriptive cohort study</td>
<td><italic>N</italic>=303 community-dwelling elders<break/>(Highest BNP group – 43% HF)<break/>Mean age 78.6–81.3<break/>HF diagnosis:<break/>HF diagnosis using medical record</td>
<td>MMSE<break/><italic>Effect of age, sex, and education included in analysis</italic></td>
<td>Elevated BNP associated with lower MMSE at baseline (β= −0.151, <italic>p</italic>=0.001)<break/>Elevated BNP associated with lower MMSE over time (β=0.140, <italic>p</italic>=0.019)</td>
</tr>
<tr>
<td>Mauro et al. (2007)<sup><xref ref-type="bibr" rid="bibr37-1474515112470046">37</xref></sup><break/><italic>Level of evidence: VI</italic><break/><italic>Italy</italic></td>
<td>Cross-sectional, descriptive</td>
<td><italic>N</italic>=60 HF patients<break/>Mean age 65.5 (range 24–87)<break/>HF diagnosis:<break/>systolic and diastolic HF using echocardiogram</td>
<td>MMSE<break/>Corsi Block Tapping<break/>Prose Memory Test<break/>Visual Search Test<break/><italic>Scores adjusted for age and education</italic></td>
<td>Elevated BNP associated with lower MMSE (<italic>r</italic>=0.25, <italic>p</italic>=0.02)</td>
</tr>
<tr>
<td>van den Hurk et al. (2011)<sup><xref ref-type="bibr" rid="bibr40-1474515112470046">40</xref></sup><break/><italic>Level of evidence: IV</italic><break/><italic>Netherlands</italic></td>
<td>Longitudinal descriptive cohort study</td>
<td><italic>N</italic>=313 community-residing adults<break/><italic>N</italic>=108 HF patients<break/>Mean age 66 (range 63–71)<break/>HF diagnosis:<break/>systolic and diastolic HF using echocardiogram</td>
<td>TMT-A<break/>TMT-B<break/>SCWI<break/>WAIS III<break/>Digit Span (forward and backward)<break/>Corsi Block Tapping<break/>RAVLT multiple<break/>Location Learning<break/>Rey Complex Figure<break/>SCWI<break/>Brixton Spatial Anticipation Test<break/>Letter Fluency<break/>Category Fluency<break/><italic>Scores adjusted for age, sex, and IQ</italic></td>
<td>Elevated BNP associated with impairments in memory (β= −0.165, <italic>p</italic>&lt;0.05), processing speed (β= −0.158, <italic>p</italic>&lt;0.05), attention and executive function (β= −0.279, <italic>p</italic>&lt;0.05)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn4-1474515112470046">
<p>BNP: B natriuretic peptide; HF: heart failure; MMSE: Mini Mental State Exam; RAVLT: Rey Auditory Verbal Learning Test; SCWI: Stroop Color Word Interference; TMT: Trail Making Test; WAIS: Wechsler Adult Intelligence Scale</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Although supporting BNP as a predictor of cognitive impairment, these studies are not without limitations. Sample sizes were broad, ranging from <italic>n</italic>=60 to <italic>n</italic>=313.<sup><xref ref-type="bibr" rid="bibr40-1474515112470046">40</xref>,<xref ref-type="bibr" rid="bibr43-1474515112470046">43</xref>,<xref ref-type="bibr" rid="bibr64-1474515112470046">64</xref></sup> Mean age ranged from 65.5 to 81.3 years,<sup><xref ref-type="bibr" rid="bibr40-1474515112470046">40</xref>,<xref ref-type="bibr" rid="bibr43-1474515112470046">43</xref>,<xref ref-type="bibr" rid="bibr64-1474515112470046">64</xref></sup> so generalizability to a younger population is a concern. Gender was inconsistent between the samples. One study was predominantly (73.3%) male<sup><xref ref-type="bibr" rid="bibr37-1474515112470046">37</xref></sup> whereas another was predominantly (74.2%) female.<sup><xref ref-type="bibr" rid="bibr64-1474515112470046">64</xref></sup> Racial composition of these samples was not reported in any of the studies. Accordingly, these limitations need to be considered before generalizations are made.</p>
<p>Renal function is routinely evaluated in patients with HF. Decreased renal function may be a sequela of prolonged HF or an adverse effect of HF medications. Findings regarding the relationship between renal function and cognitive impairment are mixed (<xref ref-type="table" rid="table7-1474515112470046">Table 7</xref>). However, different measures of renal function and cognition were used, limiting cross study comparison. Four studies, with sample sizes ranging from <italic>n</italic>=57 to <italic>n</italic>=448, supported the relationship between renal function and cognitive impairment.<sup><xref ref-type="bibr" rid="bibr17-1474515112470046">17</xref>,<xref ref-type="bibr" rid="bibr20-1474515112470046">20</xref>,<xref ref-type="bibr" rid="bibr32-1474515112470046">32</xref>,<xref ref-type="bibr" rid="bibr64-1474515112470046">64</xref></sup> Kerola et al. reported a significant relationship between creatinine clearance and MMSE score (β 0.182, <italic>p</italic>&lt;0.001).<sup><xref ref-type="bibr" rid="bibr64-1474515112470046">64</xref></sup> In another study (<italic>n</italic>=207), global cognitive function was evaluated in HF patients awaiting entry to a heart transplant program. Worse renal dysfunction was associated with lower MMSE scores (<italic>r</italic>= −0.17, <italic>p</italic>&lt;0.05).<sup><xref ref-type="bibr" rid="bibr17-1474515112470046">17</xref></sup></p>
<table-wrap id="table7-1474515112470046" position="float">
<label>Table 7.</label>
<caption>
<p>Cognition and renal function.</p>
</caption>
<graphic alternate-form-of="table7-1474515112470046" xlink:href="10.1177_1474515112470046-table7.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Study</th>
<th align="left">Design</th>
<th align="left">Sample</th>
<th align="left">Cognitive measures</th>
<th align="left">Summary of results</th>
</tr>
</thead>
<tbody>
<tr>
<td>Boodhwani et al. (2006)<sup><xref ref-type="bibr" rid="bibr20-1474515112470046">20</xref></sup><break/><italic>Level of evidence: VI</italic><break/><italic>Canada</italic></td>
<td>Longitudinal descriptive</td>
<td><italic>N</italic>=448 elders undergoing non-emergent CABG<break/>Mean age 68.3<break/>HF diagnosis:<break/>method of determining diagnosis not reported</td>
<td>Verbal List Learning<break/>Procedure (Buschke)<break/>WAIS – Revised<break/>WAIS III<break/>Digit Span<break/>TMT-A<break/>TMT-B<break/>Grooved Pegboard<break/>Symbol Digit<break/>RAVLT<break/><italic>Effect of education included in analysis</italic></td>
<td>Elevated serum creatinine predictive of cognitive decline postoperatively (OR 1.01 (95% CI 1.00–1.03) <italic>p</italic>=0.017)</td>
</tr>
<tr>
<td>Harkness et al. (2011)<sup><xref ref-type="bibr" rid="bibr34-1474515112470046">34</xref></sup><break/><italic>Level of evidence: VI</italic><break/><italic>Canada</italic></td>
<td>Cross-sectional descriptive</td>
<td><italic>N</italic>=44 elders with HF<break/>Mean age 76<break/>HF diagnosis:<break/>systolic HF using EF criteria</td>
<td>MoCA<break/><italic>Effect of age and sex included in analysis</italic></td>
<td>MoCA revealed cognitive impairment in &gt;70% of the sample<break/>No relationship between MoCA and GFR (statistical data on this variable not reported)</td>
</tr>
<tr>
<td>Kerola et al. (2010)<sup><xref ref-type="bibr" rid="bibr64-1474515112470046">64</xref></sup><break/><italic>Level of evidence: IV</italic><break/><italic>Finland</italic></td>
<td>Longitudinal descriptive cohort study</td>
<td><italic>N</italic>=303 community-dwelling elders<break/>(Highest BNP group – 43% HF)<break/>Mean age 78.6–81.3<break/>HF diagnosis:<break/>HF diagnosis using medical record</td>
<td>MMSE<break/><italic>Effect of age, sex, and education included in analysis</italic></td>
<td>Low creatinine clearance associated with lower MMSE at baseline (β=0.182, <italic>p</italic>&lt;0.001)</td>
</tr>
<tr>
<td>Mapelli et al. (2011)<sup><xref ref-type="bibr" rid="bibr17-1474515112470046">17</xref></sup><break/><italic>Level of evidence: VI</italic><break/><italic>Italy</italic></td>
<td>Cross-sectional descriptive</td>
<td><italic>N</italic>=207 patients with end-stage cardiac disease<break/>Mean age 53.33<break/>HF diagnosis:<break/>systolic HF<break/>cardiac catheterization criteria</td>
<td>MMSE<break/>Token Test<break/>TMT-A<break/>TMT-B<break/>Digit Span<break/>Logical Story<break/>Interference Memory<break/>Cognitive Estimation<break/>Abstract Verbal Reasoning<break/>Phonemic Fluency Test<break/>Clock Drawing Test<break/>Overlapping Pictures Test<break/>Spontaneous Drawing<break/>Copy Drawing<break/>Ideative and Ideomotor Praxis Test<break/><italic>Scores adjusted for age and education</italic></td>
<td>Lower index of renal dysfunction associated with increased attention (<italic>r</italic> = −0.16, <italic>p</italic>&lt;0.05)<break/>Better renal function associated with increased global cognition (<italic>r</italic>= −0.17, <italic>p</italic>&lt;0.05)</td>
</tr>
<tr>
<td>Zuccalà et al. (1997)<sup><xref ref-type="bibr" rid="bibr32-1474515112470046">32</xref></sup><break/><italic>Level of evidence: VI</italic><break/><italic>Italy</italic></td>
<td>Cross-sectional descriptive</td>
<td><italic>N</italic>=57 HF patients<break/>Mean age 77<break/>HF diagnosis:<break/>systolic HF using echocardiogram and clinical criteria</td>
<td>MMSE<break/><italic>Effect of age and sex included in analysis</italic></td>
<td>Serum creatinine associated with MMSE in initial regression analysis (β=0.50, <italic>p</italic>=0.032)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn5-1474515112470046">
<p>CI: confidence interval; EF: ejection fraction; GFR: glomerular filtration rate; HF: heart failure; MMSE: Mini Mental State Exam; OR: odds ratio; RAVLT: Rey Auditory Verbal Learning Test; TMT: Trail Making Test; WAIS: Wechsler Adult Intelligence Scale</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Only one investigator refuted the association between renal function and cognition.<sup><xref ref-type="bibr" rid="bibr34-1474515112470046">34</xref></sup> Harkness and colleagues used the Montreal Cognitive Assessment tool (MoCA) in a small sample (<italic>n</italic>=44) of older HF patients. Investigators found no relationship between MMSE score and glomerular filtration rate (GFR).<sup><xref ref-type="bibr" rid="bibr34-1474515112470046">34</xref></sup> The mean age for these samples ranged from 53.3 to 78.6 years.<sup><xref ref-type="bibr" rid="bibr17-1474515112470046">17</xref>,<xref ref-type="bibr" rid="bibr20-1474515112470046">20</xref>,<xref ref-type="bibr" rid="bibr32-1474515112470046">32</xref>,<xref ref-type="bibr" rid="bibr34-1474515112470046">34</xref>,<xref ref-type="bibr" rid="bibr64-1474515112470046">64</xref></sup> Gender composition was inconsistent, with one study predominantly (87%) male whereas another was predominantly (74.2%) female. Race was not reported in these studies likely due to the geographic location of the studies (Canada, Finland, Italy). Although these studies show promise, these factors limit generalizability of the results. Overall, the strength of the relationship between renal function and cognition is less than certain.</p>
<p>Lastly, three studies with sample sizes ranging from <italic>n</italic>=57 to <italic>n</italic>=580 evaluated the relationship of lipid levels and cognitive impairment (<xref ref-type="table" rid="table8-1474515112470046">Table 8</xref>).<sup><xref ref-type="bibr" rid="bibr32-1474515112470046">32</xref>,<xref ref-type="bibr" rid="bibr54-1474515112470046">54</xref>,<xref ref-type="bibr" rid="bibr64-1474515112470046">64</xref></sup> Similar to studies of renal function and cognition, lipids and cognition were measured differently between studies. Two studies examined global cognition using the MMSE.<sup><xref ref-type="bibr" rid="bibr32-1474515112470046">32</xref>,<xref ref-type="bibr" rid="bibr64-1474515112470046">64</xref></sup> Kerola found no relationship between MMSE score and total cholesterol or low-density lipoproteins (LDLs). However, elevated high-density lipoprotein (HDL) was predictive of better baseline performance on the MMSE (β=0.174, <italic>p</italic>=0.001), but not decline in score over time.<sup><xref ref-type="bibr" rid="bibr64-1474515112470046">64</xref></sup> Zuccalà et al. evaluated total cholesterol in 57 patients with chronic HF and reported that lower total cholesterol levels were related to lower MMSE scores (<italic>r</italic>=0.30, <italic>p</italic>=0.02).<sup><xref ref-type="bibr" rid="bibr32-1474515112470046">32</xref></sup> Hajjar et al., by comparison, administered a short battery of tests to 580 participants to identify a phenotype for cardiovascular risk.<sup><xref ref-type="bibr" rid="bibr54-1474515112470046">54</xref></sup> The phenotype for cardiovascular risk as opposed to normal controls had slow gait speed, impaired executive function and symptoms of depression. Elevated LDL was associated with this phenotype but a correlation between LDL and executive function was not specifically examined.<sup><xref ref-type="bibr" rid="bibr54-1474515112470046">54</xref></sup></p>
<table-wrap id="table8-1474515112470046" position="float">
<label>Table 8.</label>
<caption>
<p>Cognition and lipid levels.</p>
</caption>
<graphic alternate-form-of="table8-1474515112470046" xlink:href="10.1177_1474515112470046-table8.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Study</th>
<th align="left">Design</th>
<th align="left">Sample</th>
<th align="left">Cognitive measures</th>
<th align="left">Summary of results</th>
</tr>
</thead>
<tbody>
<tr>
<td>Hajjar et al. (2009)<sup><xref ref-type="bibr" rid="bibr54-1474515112470046">54</xref></sup><break/><italic>USA</italic></td>
<td>Cross-sectional</td>
<td><italic>N</italic>=580 community-dwelling elders (10% in low performance group had HF)<break/>Mean age 77.8<break/>HF diagnosis:<break/>self-report</td>
<td>HVLT – Revised<break/>TMT-A<break/>TMT-B<break/><italic>Scores adjusted for age, education and race</italic></td>
<td>A group of elderly individuals with a phenotype of slow gait speed, greater depressive symptoms and worse executive function exists<break/>Elevated LDL is associated with being a member of this group (OR 1.01, 95% CI 1.00–1.02)</td>
</tr>
<tr>
<td>Kerola et al. (2010)<sup><xref ref-type="bibr" rid="bibr64-1474515112470046">64</xref></sup><break/><italic>Level of evidence: IV</italic><break/><italic>Finland</italic></td>
<td>Longitudinal descriptive cohort study</td>
<td><italic>N</italic>=303 community-dwelling elders<break/>(Highest BNP group – 43% HF)<break/>Mean age 78.6–81.3<break/>HF diagnosis:<break/>HF diagnosis using medical record</td>
<td>MMSE<break/><italic>Effect of age, sex, and education included in analysis</italic></td>
<td>Low HDL associated with lower MMSE at baseline (β=0.174, <italic>p</italic>=0.001)</td>
</tr>
<tr>
<td>Zuccalà et al. (1997)<sup><xref ref-type="bibr" rid="bibr32-1474515112470046">32</xref></sup><break/><italic>Level of evidence: VI</italic><break/><italic>Italy</italic></td>
<td>Cross-sectional descriptive</td>
<td><italic>N</italic>=57 HF patients<break/>Mean age 77<break/>HF diagnosis:<break/>systolic HF using echocardiogram and clinical criteria</td>
<td>MMSE<break/><italic>Effect of age and sex included in analysis</italic></td>
<td>Lower serum cholesterol associated with lower MMSE scores (<italic>r</italic>=0.30, <italic>p</italic>=0.02)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn6-1474515112470046">
<p>BNP: B natriuretic peptide; CI: confidence interval; HF: heart failure; LDL: low-density lipoprotein; MMSE: Mini Mental State Exam; OR: odds ratio; HVLT: Hopkins Verbal Learning Test; TMT: Trail Making Test</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The multiple variables evaluated in these studies limit our ability to compare them or make predictions about the population as a whole. These studies also are limited by age, gender and race. The mean age was older and ranged from 76.7 to 78.6 years.<sup><xref ref-type="bibr" rid="bibr32-1474515112470046">32</xref>,<xref ref-type="bibr" rid="bibr54-1474515112470046">54</xref>,<xref ref-type="bibr" rid="bibr64-1474515112470046">64</xref></sup> Contrary to most other studies, these studies were predominantly (64% to 74.2%) female.<sup><xref ref-type="bibr" rid="bibr32-1474515112470046">32</xref>,<xref ref-type="bibr" rid="bibr54-1474515112470046">54</xref>,<xref ref-type="bibr" rid="bibr64-1474515112470046">64</xref></sup> One study reported 80% of participants self-described as White.<sup><xref ref-type="bibr" rid="bibr54-1474515112470046">54</xref></sup> Race was not reported in the remaining two studies, again likely due to geographic location.<sup><xref ref-type="bibr" rid="bibr32-1474515112470046">32</xref>,<xref ref-type="bibr" rid="bibr64-1474515112470046">64</xref></sup> Based on the limitations together with inconclusive results, generalizations about lipids and cognitive function cannot be made.</p>
</sec>
</sec>
<sec id="section12-1474515112470046" sec-type="discussion">
<title>Discussion</title>
<p>Based on our review of the literature, published evidence to date supports the potential usefulness of severe systolic dysfunction (lower EF), lower BP, lower functional status and elevated BNP as markers of a phenotype of increased risk for cognitive impairment. To the best of our knowledge, the proposed phenotype for mild cognitive impairment among patients with HF is novel. These objective cardiac variables are frequently assessed as part of treatment for HF and are more practical than extensive neurocognitive batteries for identification of mild cognitive impairment. Though not causative of cognitive impairment, they are possible indicators of patients who may have mild cognitive deficits that otherwise may not be identified. Relationships have been identified between cognitive impairment and other laboratory tests (renal function, lipid levels), but variability in the markers used makes it difficult to generalize regarding their reliability. Other factors reportedly associated with risk for cognitive impairment include increased age, lower education, depressive symptoms and male gender.<sup><xref ref-type="bibr" rid="bibr6-1474515112470046">6</xref>,<xref ref-type="bibr" rid="bibr8-1474515112470046">8</xref>,<xref ref-type="bibr" rid="bibr51-1474515112470046">51</xref>,<xref ref-type="bibr" rid="bibr65-1474515112470046">65</xref>,<xref ref-type="bibr" rid="bibr71-1474515112470046">71</xref></sup> All of these variables are simple to assess and may indicate the need for more comprehensive interventions to support self-care after discharge to home. However, it is important to acknowledge that without prospective testing, we cannot hypothesize as to the relative importance of each variable in the proposed phenotype for predicting cognitive impairment risk. The analyses and strength of the relationship between the variables of interest and cognitive impairment differed across studies limiting cross comparison. The majority of studies were descriptive in nature using case control or cohort methodology<sup><xref ref-type="bibr" rid="bibr18-1474515112470046">18</xref></sup> as opposed to evidence from randomized trials. However, descriptive studies are appropriate for examining the relationship between the proposed phenotypic variables and mild cognitive impairment risk.</p>
<p>The relationship between cognitive impairment and self-care has been identified.<sup><xref ref-type="bibr" rid="bibr10-1474515112470046">10</xref>,<xref ref-type="bibr" rid="bibr34-1474515112470046">34</xref></sup> Once, or if, risk for cognitive impairment is suspected (e.g. HF patients with low EF, systolic BP &lt; 130, low functional status, elevated BNP, low educational level and advanced age) specific evaluations of cognition can be considered. In the hospital setting, a brief reliable and valid screening tool is desirable. The MoCA can be completed in 10 minutes and does not require extensive training to administer.<sup><xref ref-type="bibr" rid="bibr6-1474515112470046">6</xref>,<xref ref-type="bibr" rid="bibr13-1474515112470046">13</xref></sup> Scores range from 0 to 30 with lower scores indicating worse cognitive function. Scores &lt; 26 indicate cognitive impairment. This tool is more sensitive to mild cognitive impairment in patients with HF.<sup><xref ref-type="bibr" rid="bibr34-1474515112470046">34</xref>,<xref ref-type="bibr" rid="bibr72-1474515112470046">72</xref></sup> Furthermore, by decreasing the cut off to 24 for patients with cardiovascular disease, the authors report increased specificity without sacrificing sensitivity in this population.<sup><xref ref-type="bibr" rid="bibr72-1474515112470046">72</xref></sup></p>
<p>Cognitive impairment in HF patients can be subtle. The insidious nature of HF can result in an individual who is able to function normally in society but unable to carry out the more complex functions of disease management instrumental to self-care.<sup><xref ref-type="bibr" rid="bibr5-1474515112470046">5</xref></sup> When planning care, clinicians could consider the potential value of tests in the proposed phenotype, particularly in relation to discharge education and follow-up care. Should a patient admitted with HF meet this phenotypic profile, screening for mild cognitive impairment may be considered. Once cognitive impairment is established, early interventions such as family involvement, frequent follow-up and education can be incorporated into disease management. Tailored strategies may help patients manage their HF more effectively and ultimately reduce risk for repeated hospitalizations for symptom management.</p>
</sec>
<sec id="section13-1474515112470046">
<title>Research implications</title>
<p>Studies in this review were typically composed of older adults, Caucasians and males. Research is needed with diverse samples to confirm the phenotype. Although suggestive of associations with cognitive impairment, research investigating HF-related laboratory tests is by no means comprehensive. Only three studies evaluating BNP and cognitive impairment were identified. In addition, studies investigating renal function and lipids used different markers. Standardization of variables would strengthen the argument in favor of these indicators of risk for cognitive impairment. This literature review indicates a potential phenotype for mild cognitive impairment risk for patients with HF. However, prospective research evaluating the effectiveness of HF severity (EF), lower systolic BP, functional status and HF-related laboratory tests as markers is needed to support or refute the phenotype. Finally, prospective studies are needed to examine the relative value of each marker and determine meaningful parameters.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p>
</fn>
<fn fn-type="conflict">
<label>Conflict of interest</label>
<p>None declared.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1474515112470046">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Roger</surname><given-names>VL</given-names></name>
<name><surname>Go</surname><given-names>AS</given-names></name>
<name><surname>Lloyd-Jones</surname><given-names>DM</given-names></name>
<etal/></person-group>. <article-title>Heart disease and stroke statistics – 2012 update: A report from the American Heart Association</article-title>. <source>Circulation</source> <year>2012</year>; <volume>125</volume>: <fpage>e2</fpage>-<lpage>e220</lpage>.</citation>
</ref>
<ref id="bibr2-1474515112470046">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Riegel</surname><given-names>B</given-names></name>
<name><surname>Moser</surname><given-names>DK</given-names></name>
<name><surname>Anker</surname><given-names>SD</given-names></name>
<etal/></person-group>. <article-title>State of the science: Promoting self-care in persons with heart failure: A scientific statement from the American Heart Association</article-title>. <source>Circulation</source> <year>2009</year>; <volume>120</volume>: <fpage>1141</fpage>–<lpage>1163</lpage>.</citation>
</ref>
<ref id="bibr3-1474515112470046">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lindenfeld</surname><given-names>J</given-names></name>
<name><surname>Albert</surname><given-names>NM</given-names></name>
<name><surname>Boehmer</surname><given-names>JP</given-names></name>
<etal/></person-group>. <article-title>HFSA 2010 Comprehensive Heart Failure Practice Guideline</article-title>. <source>J Card Fail</source> <year>2010</year>; <volume>16</volume>: <fpage>e1</fpage>–<lpage>e194</lpage>.</citation>
</ref>
<ref id="bibr4-1474515112470046">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Almeida</surname><given-names>OP</given-names></name>
<name><surname>Tamai</surname><given-names>S</given-names></name>
</person-group>. <article-title>Congestive heart failure and cognitive functioning amongst older adults</article-title>. <source>Arq Neuropsiquiatr</source> <year>2001</year>; <volume>59</volume>: <fpage>324</fpage>–<lpage>329</lpage>.</citation>
</ref>
<ref id="bibr5-1474515112470046">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vogels</surname><given-names>RL</given-names></name>
<name><surname>Scheltens</surname><given-names>P</given-names></name>
<name><surname>Schroeder-Tanka</surname><given-names>JM</given-names></name>
<etal/></person-group>. <article-title>Cognitive impairment in heart failure: A systematic review of the literature</article-title>. <source>Eur J Heart Fail</source> <year>2007</year>; <volume>9</volume>: <fpage>440</fpage>–<lpage>449</lpage>.</citation>
</ref>
<ref id="bibr6-1474515112470046">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bauer</surname><given-names>LC</given-names></name>
<name><surname>Johnson</surname><given-names>JK</given-names></name>
<name><surname>Pozehl</surname><given-names>BJ</given-names></name>
</person-group>. <article-title>Cognition in heart failure: an overview of the concepts and their measures</article-title>. <source>J Am Acad Nurse Pract</source> <year>2011</year>; <volume>23</volume>: <fpage>577</fpage>–<lpage>585</lpage>.</citation>
</ref>
<ref id="bibr7-1474515112470046">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bennett</surname><given-names>SJ</given-names></name>
<name><surname>Sauve</surname><given-names>MJ</given-names></name>
</person-group>. <article-title>Cognitive deficits in patients with heart failure: A review of the literature</article-title>. <source>J Cardiovasc Nurs</source> <year>2003</year>; <volume>18</volume>: <fpage>219</fpage>–<lpage>242</lpage>.</citation>
</ref>
<ref id="bibr8-1474515112470046">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bennett</surname><given-names>SJ</given-names></name>
<name><surname>Sauve</surname><given-names>MJ</given-names></name>
<name><surname>Shaw</surname><given-names>RM</given-names></name>
</person-group>. <article-title>A conceptual model of cognitive deficits in chronic heart failure</article-title>. <source>J Nurs Scholarsh</source> <year>2005</year>; <volume>37</volume>: <fpage>222</fpage>–<lpage>228</lpage>.</citation>
</ref>
<ref id="bibr9-1474515112470046">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cameron</surname><given-names>J</given-names></name>
<name><surname>Worrall-Carter</surname><given-names>L</given-names></name>
<name><surname>Page</surname><given-names>K</given-names></name>
<etal/></person-group>. <article-title>Does cognitive impairment predict poor self-care in patients with heart failure?</article-title> <source>Eur J Heart Fail</source> <year>2010</year>; <volume>12</volume>: <fpage>508</fpage>–<lpage>515</lpage>.</citation>
</ref>
<ref id="bibr10-1474515112470046">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gaviria</surname><given-names>M</given-names></name>
<name><surname>Pliskin</surname><given-names>N</given-names></name>
<name><surname>Kney</surname><given-names>A</given-names></name>
</person-group>. <article-title>Cognitive impairment in patients with advanced heart failure and its implications on decision-making capacity</article-title>. <source>Congest Heart Fail</source> <year>2011</year>; <volume>17</volume>: <fpage>175</fpage>–<lpage>179</lpage>.</citation>
</ref>
<ref id="bibr11-1474515112470046">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Woo</surname><given-names>MA</given-names></name>
<name><surname>Macey</surname><given-names>PM</given-names></name>
<name><surname>Fonarow</surname><given-names>GC</given-names></name>
<etal/></person-group>. <article-title>Regional brain gray matter loss in heart failure</article-title>. <source>J Appl Physiol</source> <year>2003</year>; <volume>95</volume>: <fpage>677</fpage>–<lpage>684</lpage>.</citation>
</ref>
<ref id="bibr12-1474515112470046">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Portet</surname><given-names>F</given-names></name>
<name><surname>Ousset</surname><given-names>PJ</given-names></name>
<name><surname>Visser</surname><given-names>PJ</given-names></name>
<etal/></person-group>. <article-title>Mild cognitive impairment (MCI) in medical practice: A critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer’s Disease</article-title>. <source>J Neurol Neurosurg Psychiatry</source> <year>2006</year>; <volume>77</volume>: <fpage>714</fpage>–<lpage>718</lpage>.</citation>
</ref>
<ref id="bibr13-1474515112470046">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nasreddine</surname><given-names>ZS</given-names></name>
<name><surname>Phillips</surname><given-names>NA</given-names></name>
<name><surname>Bedirian</surname><given-names>V</given-names></name>
<etal/></person-group>. <article-title>The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment</article-title>. <source>J Am Geriatr Soc</source> <year>2005</year>; <volume>53</volume>: <fpage>695</fpage>–<lpage>699</lpage>.</citation>
</ref>
<ref id="bibr14-1474515112470046">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Petersen</surname><given-names>RC</given-names></name>
<name><surname>Smith</surname><given-names>GE</given-names></name>
<name><surname>Waring</surname><given-names>SC</given-names></name>
<etal/></person-group>. <article-title>Mild cognitive impairment: Clinical characterization and outcome</article-title>. <source>Arch Neurol</source> <year>1999</year>; <volume>56</volume>: <fpage>303</fpage>–<lpage>308</lpage>.</citation>
</ref>
<ref id="bibr15-1474515112470046">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dickson</surname><given-names>VV</given-names></name>
<name><surname>Tkacs</surname><given-names>N</given-names></name>
<name><surname>Riegel</surname><given-names>B</given-names></name>
</person-group>. <article-title>Cognitive influences on self-care decision making in persons with heart failure</article-title>. <source>Am Heart J</source> <year>2007</year>; <volume>154</volume>: <fpage>424</fpage>–<lpage>431</lpage>.</citation>
</ref>
<ref id="bibr16-1474515112470046">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pressler</surname><given-names>SJ</given-names></name>
<name><surname>Kim</surname><given-names>J</given-names></name>
<name><surname>Riley</surname><given-names>P</given-names></name>
<etal/></person-group>. <article-title>Memory dysfunction, psychomotor slowing, and decreased executive function predict mortality in patients with heart failure and low ejection fraction</article-title>. <source>J Card Fail</source> <year>2010</year>; <volume>16</volume>: <fpage>750</fpage>–<lpage>760</lpage>.</citation>
</ref>
<ref id="bibr17-1474515112470046">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mapelli</surname><given-names>D</given-names></name>
<name><surname>Bardi</surname><given-names>L</given-names></name>
<name><surname>Mojoli</surname><given-names>M</given-names></name>
<etal/></person-group>. <article-title>Neuropsychological profile in a large group of heart transplant candidates</article-title>. <source>PLoS One</source> <year>2011</year>; <volume>6</volume>: <fpage>e28313</fpage>.</citation>
</ref>
<ref id="bibr18-1474515112470046">
<label>18.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Melnyk</surname><given-names>BM</given-names></name>
<name><surname>Fineout-Overholt</surname><given-names>E</given-names></name>
</person-group>. <source>Evidence-based Practice in Nursing &amp; Healthcare: A Guide to Best Practice</source>. <edition>2nd ed.</edition> <publisher-loc>Philadelphia</publisher-loc>: <publisher-name>Wolters Kluwer/Lippincott Williams &amp; Wilkins</publisher-name>, <year>2011</year>.</citation>
</ref>
<ref id="bibr19-1474515112470046">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Argiriadou</surname><given-names>H</given-names></name>
<name><surname>Megari</surname><given-names>K</given-names></name>
<name><surname>Antonitsis</surname><given-names>P</given-names></name>
<etal/></person-group>. <article-title>Non-pulsatile circulation with axial-flow left ventricular assist device preserves neurocognitive function</article-title>. <source>Perfusion</source> <year>2010</year>; <volume>25</volume>: <fpage>225</fpage>–<lpage>228</lpage>.</citation>
</ref>
<ref id="bibr20-1474515112470046">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Boodhwani</surname><given-names>M</given-names></name>
<name><surname>Rubens</surname><given-names>FD</given-names></name>
<name><surname>Wozny</surname><given-names>D</given-names></name>
<etal/></person-group>. <article-title>Predictors of early neurocognitive deficits in low-risk patients undergoing on-pump coronary artery bypass surgery</article-title>. <source>Circulation</source> <year>2006</year>; <volume>114</volume>: <fpage>I461</fpage>–<lpage>I466</lpage>.</citation>
</ref>
<ref id="bibr21-1474515112470046">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dickson</surname><given-names>VV</given-names></name>
<name><surname>Deatrick</surname><given-names>JA</given-names></name>
<name><surname>Riegel</surname><given-names>B</given-names></name>
</person-group>. <article-title>A typology of heart failure self-care management in non-elders</article-title>. <source>Eur J Cardiovasc Nurs</source> <year>2008</year>; <volume>7</volume>: <fpage>171</fpage>–<lpage>181</lpage>.</citation>
</ref>
<ref id="bibr22-1474515112470046">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dixit</surname><given-names>NK</given-names></name>
<name><surname>Vazquez</surname><given-names>LD</given-names></name>
<name><surname>Cross</surname><given-names>NJ</given-names></name>
<etal/></person-group>. <article-title>Cardiac resynchronization therapy: A pilot study examining cognitive change in patients before and after treatment</article-title>. <source>Clin Cardiol</source> <year>2010</year>; <volume>33</volume>: <fpage>84</fpage>–<lpage>88</lpage>.</citation>
</ref>
<ref id="bibr23-1474515112470046">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Festa</surname><given-names>JR</given-names></name>
<name><surname>Jia</surname><given-names>X</given-names></name>
<name><surname>Cheung</surname><given-names>K</given-names></name>
<etal/></person-group>. <article-title>Association of low ejection fraction with impaired verbal memory in older patients with heart failure</article-title>. <source>Arch Neurol</source> <year>2011</year>; <volume>68</volume>: <fpage>1021</fpage>–<lpage>1026</lpage>.</citation>
</ref>
<ref id="bibr24-1474515112470046">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gottesman</surname><given-names>RF</given-names></name>
<name><surname>Grega</surname><given-names>MA</given-names></name>
<name><surname>Bailey</surname><given-names>MM</given-names></name>
<etal/></person-group>. <article-title>Association between hypotension, low ejection fraction and cognitive performance in cardiac patients</article-title>. <source>Behav Neurol</source> <year>2010</year>; <volume>22</volume>: <fpage>63</fpage>–<lpage>71</lpage>.</citation>
</ref>
<ref id="bibr25-1474515112470046">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hoth</surname><given-names>KF</given-names></name>
<name><surname>Poppas</surname><given-names>A</given-names></name>
<name><surname>Ellison</surname><given-names>KE</given-names></name>
<etal/></person-group>. <article-title>Link between change in cognition and left ventricular function following cardiac resynchronization therapy</article-title>. <source>J Cardiopulm Rehabil Prev</source> <year>2010</year>; <volume>30</volume>: <fpage>401</fpage>–<lpage>408</lpage>.</citation>
</ref>
<ref id="bibr26-1474515112470046">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hoth</surname><given-names>KF</given-names></name>
<name><surname>Poppas</surname><given-names>A</given-names></name>
<name><surname>Moser</surname><given-names>DJ</given-names></name>
<etal/></person-group>. <article-title>Cardiac dysfunction and cognition in older adults with heart failure</article-title>. <source>Cogn Behav Neurol</source> <year>2008</year>; <volume>21</volume>: <fpage>65</fpage>–<lpage>72</lpage>.</citation>
</ref>
<ref id="bibr27-1474515112470046">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jefferson</surname><given-names>AL</given-names></name>
<name><surname>Himali</surname><given-names>JJ</given-names></name>
<name><surname>Au</surname><given-names>R</given-names></name>
<etal/></person-group>. <article-title>Relation of left ventricular ejection fraction to cognitive aging (from the Framingham Heart Study)</article-title>. <source>Am J Cardiol</source> <year>2011</year>; <volume>108</volume>: <fpage>1346</fpage>–<lpage>1351</lpage>.</citation>
</ref>
<ref id="bibr28-1474515112470046">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jerskey</surname><given-names>BA</given-names></name>
<name><surname>Cohen</surname><given-names>RA</given-names></name>
<name><surname>Jefferson</surname><given-names>AL</given-names></name>
<etal/></person-group>. <article-title>Sustained attention is associated with left ventricular ejection fraction in older adults with heart disease</article-title>. <source>J Int Neuropsychol Soc</source> <year>2009</year>; <volume>15</volume>: <fpage>137</fpage>–<lpage>141</lpage>.</citation>
</ref>
<ref id="bibr29-1474515112470046">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Moser</surname><given-names>DJ</given-names></name>
<name><surname>Cohen</surname><given-names>RA</given-names></name>
<name><surname>Clark</surname><given-names>MM</given-names></name>
<etal/></person-group>. <article-title>Neuropsychological functioning among cardiac rehabilitation patients</article-title>. <source>J Cardiopulm Rehabil</source> <year>1999</year>; <volume>19</volume>: <fpage>91</fpage>–<lpage>97</lpage>.</citation>
</ref>
<ref id="bibr30-1474515112470046">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Petrucci</surname><given-names>RJ</given-names></name>
<name><surname>Rogers</surname><given-names>JG</given-names></name>
<name><surname>Blue</surname><given-names>L</given-names></name>
<etal/></person-group>. <article-title>Neurocognitive function in destination therapy patients receiving continuous-flow vs pulsatile-flow left ventricular assist device support</article-title>. <source>J Heart Lung Transplant</source> <year>2012</year>; <volume>31</volume>: <fpage>27</fpage>–<lpage>36</lpage>.</citation>
</ref>
<ref id="bibr31-1474515112470046">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tanne</surname><given-names>D</given-names></name>
<name><surname>Freimark</surname><given-names>D</given-names></name>
<name><surname>Poreh</surname><given-names>A</given-names></name>
<etal/></person-group>. <article-title>Cognitive functions in severe congestive heart failure before and after an exercise training program</article-title>. <source>Int J Cardiol</source> <year>2005</year>; <volume>103</volume>: <fpage>145</fpage>–<lpage>149</lpage>.</citation>
</ref>
<ref id="bibr32-1474515112470046">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zuccalà</surname><given-names>G</given-names></name>
<name><surname>Cattel</surname><given-names>C</given-names></name>
<name><surname>Manes-Gravina</surname><given-names>E</given-names></name>
<etal/></person-group>. <article-title>Left ventricular dysfunction: A clue to cognitive impairment in older patients with heart failure</article-title>. <source>J Neurol Neurosurg Psychiatry</source> <year>1997</year>; <volume>63</volume>: <fpage>509</fpage>–<lpage>512</lpage>.</citation>
</ref>
<ref id="bibr33-1474515112470046">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Folstein</surname><given-names>MF</given-names></name>
<name><surname>Folstein</surname><given-names>SE</given-names></name>
<name><surname>McHugh</surname><given-names>PR</given-names></name>
</person-group>. <article-title>“Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician</article-title>. <source>J Psychiatr Res</source> <year>1975</year>; <volume>12</volume>: <fpage>189</fpage>–<lpage>198</lpage>.</citation>
</ref>
<ref id="bibr34-1474515112470046">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Harkness</surname><given-names>K</given-names></name>
<name><surname>Demers</surname><given-names>C</given-names></name>
<name><surname>Heckman</surname><given-names>GA</given-names></name>
<etal/></person-group>. <article-title>Screening for cognitive deficits using the Montreal cognitive assessment tool in outpatients &gt;/=65 years of age with heart failure</article-title>. <source>Am J Cardiol</source> <year>2011</year>; <volume>107</volume>: <fpage>1203</fpage>–<lpage>1207</lpage>.</citation>
</ref>
<ref id="bibr35-1474515112470046">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Folstein</surname><given-names>M</given-names></name>
</person-group>. <article-title>Mini-mental and son</article-title>. <source>Int J Geriatr Psychiatry</source> <year>1998</year>; <volume>13</volume>: <fpage>290</fpage>–<lpage>294</lpage>.</citation>
</ref>
<ref id="bibr36-1474515112470046">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Almeida</surname><given-names>OP</given-names></name>
<name><surname>Beer</surname><given-names>C</given-names></name>
<name><surname>Lautenschlager</surname><given-names>NT</given-names></name>
<etal/></person-group>. <article-title>Two-year course of cognitive function and mood in adults with congestive heart failure and coronary artery disease: The Heart–Mind Study</article-title>. <source>Int Psychogeriatr</source> <year>2012</year>; <volume>24</volume>: <fpage>38</fpage>–<lpage>47</lpage>.</citation>
</ref>
<ref id="bibr37-1474515112470046">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mauro</surname><given-names>F</given-names></name>
<name><surname>Rosso</surname><given-names>GL</given-names></name>
<name><surname>Peano</surname><given-names>M</given-names></name>
<etal/></person-group>. <article-title>Correlation between cognitive impairment and prognostic parameters in patients with congestive heart failure</article-title>. <source>Arch Med Res</source> <year>2007</year>; <volume>38</volume>: <fpage>234</fpage>–<lpage>239</lpage>.</citation>
</ref>
<ref id="bibr38-1474515112470046">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sauve</surname><given-names>MJ</given-names></name>
<name><surname>Lewis</surname><given-names>WR</given-names></name>
<name><surname>Blankenbiller</surname><given-names>M</given-names></name>
<etal/></person-group>. <article-title>Cognitive impairments in chronic heart failure: A case controlled study</article-title>. <source>J Card Fail</source> <year>2009</year>; <volume>15</volume>: <fpage>1</fpage>–<lpage>10</lpage>.</citation>
</ref>
<ref id="bibr39-1474515112470046">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stanek</surname><given-names>KM</given-names></name>
<name><surname>Gunstad</surname><given-names>J</given-names></name>
<name><surname>Paul</surname><given-names>RH</given-names></name>
<etal/></person-group>. <article-title>Longitudinal cognitive performance in older adults with cardiovascular disease: Evidence for improvement in heart failure</article-title>. <source>J Cardiovasc Nurs</source> <year>2009</year>; <volume>24</volume>: <fpage>192</fpage>–<lpage>197</lpage>.</citation>
</ref>
<ref id="bibr40-1474515112470046">
<label>40.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>van den Hurk</surname><given-names>K</given-names></name>
<name><surname>Reijmer</surname><given-names>YD</given-names></name>
<name><surname>van den Berg</surname><given-names>E</given-names></name>
<etal/></person-group>. <article-title>Heart failure and cognitive function in the general population: The Hoorn Study</article-title>. <source>Eur J Heart Fail</source> <year>2011</year>; <volume>13</volume>: <fpage>1362</fpage>–<lpage>1369</lpage>.</citation>
</ref>
<ref id="bibr41-1474515112470046">
<label>41.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vogels</surname><given-names>RL</given-names></name>
<name><surname>Oosterman</surname><given-names>JM</given-names></name>
<name><surname>van Harten</surname><given-names>B</given-names></name>
<etal/></person-group>. <article-title>Profile of cognitive impairment in chronic heart failure</article-title>. <source>J Am Geriatr Soc</source> <year>2007</year>; <volume>55</volume>: <fpage>1764</fpage>–<lpage>1770</lpage>.</citation>
</ref>
<ref id="bibr42-1474515112470046">
<label>42.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wolfe</surname><given-names>R</given-names></name>
<name><surname>Worrall-Carter</surname><given-names>L</given-names></name>
<name><surname>Foister</surname><given-names>K</given-names></name>
<etal/></person-group>. <article-title>Assessment of cognitive function in heart failure patients</article-title>. <source>Eur J Cardiovasc Nurs</source> <year>2006</year>; <volume>5</volume>: <fpage>158</fpage>–<lpage>164</lpage>.</citation>
</ref>
<ref id="bibr43-1474515112470046">
<label>43.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Feola</surname><given-names>M</given-names></name>
<name><surname>Rosso</surname><given-names>GL</given-names></name>
<name><surname>Peano</surname><given-names>M</given-names></name>
<etal/></person-group>. <article-title>Correlation between cognitive impairment and prognostic parameters in patients with congestive heart failure</article-title>. <source>Arch Med Res</source> <year>2007</year>; <volume>38</volume>: <fpage>234</fpage>–<lpage>239</lpage>.</citation>
</ref>
<ref id="bibr44-1474515112470046">
<label>44.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Huynh</surname><given-names>BC</given-names></name>
<name><surname>Rovner</surname><given-names>A</given-names></name>
<name><surname>Rich</surname><given-names>MW</given-names></name>
</person-group>. <article-title>Long-term survival in elderly patients hospitalized for heart failure: 14-year follow-up from a prospective randomized trial</article-title>. <source>Arch Intern Med</source> <year>2006</year>; <volume>166</volume>: <fpage>1892</fpage>–<lpage>1898</lpage>.</citation>
</ref>
<ref id="bibr45-1474515112470046">
<label>45.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kuo</surname><given-names>HK</given-names></name>
<name><surname>Sorond</surname><given-names>F</given-names></name>
<name><surname>Iloputaife</surname><given-names>I</given-names></name>
<etal/></person-group>. <article-title>Effect of blood pressure on cognitive functions in elderly persons</article-title>. <source>J Gerontol A Biol Sci Med Sci</source> <year>2004</year>; <volume>59</volume>: <fpage>1191</fpage>–<lpage>1194</lpage>.</citation>
</ref>
<ref id="bibr46-1474515112470046">
<label>46.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Levy</surname><given-names>WC</given-names></name>
<name><surname>Mozaffarian</surname><given-names>D</given-names></name>
<name><surname>Linker</surname><given-names>DT</given-names></name>
<etal/></person-group>. <article-title>The Seattle Heart Failure Model: Prediction of survival in heart failure</article-title>. <source>Circulation</source> <year>2006</year>; <volume>113</volume>: <fpage>1424</fpage>–<lpage>1433</lpage>.</citation>
</ref>
<ref id="bibr47-1474515112470046">
<label>47.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Aronow</surname><given-names>WS</given-names></name>
<name><surname>Fleg</surname><given-names>JL</given-names></name>
<name><surname>Pepine</surname><given-names>CJ</given-names></name>
<etal/></person-group>. <article-title>ACCF/AHA 2011 expert consensus document on hypertension in the elderly: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents</article-title>. <source>Circulation</source> <year>2011</year>; <volume>123</volume>: <fpage>2434</fpage>–<lpage>2506</lpage>.</citation>
</ref>
<ref id="bibr48-1474515112470046">
<label>48.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gheorghiade</surname><given-names>M</given-names></name>
<name><surname>Abraham</surname><given-names>WT</given-names></name>
<name><surname>Albert</surname><given-names>NM</given-names></name>
<etal/></person-group>. <article-title>Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure</article-title>. <source>JAMA</source> <year>2006</year>; <volume>296</volume>: <fpage>2217</fpage>–<lpage>2226</lpage>.</citation>
</ref>
<ref id="bibr49-1474515112470046">
<label>49.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cacciatore</surname><given-names>F</given-names></name>
<name><surname>Abete</surname><given-names>P</given-names></name>
<name><surname>Ferrara</surname><given-names>N</given-names></name>
<etal/></person-group>. <article-title>Congestive heart failure and cognitive impairment in an older population. Osservatorio Geriatrico Campano Study Group</article-title>. <source>J Am Geriatr Soc</source> <year>1998</year>; <volume>46</volume>: <fpage>1343</fpage>–<lpage>1348</lpage>.</citation>
</ref>
<ref id="bibr50-1474515112470046">
<label>50.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Qiu</surname><given-names>C</given-names></name>
<name><surname>Winblad</surname><given-names>B</given-names></name>
<name><surname>Marengoni</surname><given-names>A</given-names></name>
<etal/></person-group>. <article-title>Heart failure and risk of dementia and Alzheimer disease: A population-based cohort study</article-title>. <source>Arch Intern Med</source> <year>2006</year>; <volume>166</volume>: <fpage>1003</fpage>–<lpage>1008</lpage>.</citation>
</ref>
<ref id="bibr51-1474515112470046">
<label>51.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zuccalà</surname><given-names>G</given-names></name>
<name><surname>Marzetti</surname><given-names>E</given-names></name>
<name><surname>Cesari</surname><given-names>M</given-names></name>
<etal/></person-group>. <article-title>Correlates of cognitive impairment among patients with heart failure: Results of a multicenter survey</article-title>. <source>Am J Med</source> <year>2005</year>; <volume>118</volume>: <fpage>496</fpage>–<lpage>502</lpage>.</citation>
</ref>
<ref id="bibr52-1474515112470046">
<label>52.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zuccalà</surname><given-names>G</given-names></name>
<name><surname>Onder</surname><given-names>G</given-names></name>
<name><surname>Pedone</surname><given-names>C</given-names></name>
<etal/></person-group>. <article-title>Hypotension and cognitive impairment: Selective association in patients with heart failure</article-title>. <source>Neurology</source> <year>2001</year>; <volume>57</volume>: <fpage>1986</fpage>–<lpage>1992</lpage>.</citation>
</ref>
<ref id="bibr53-1474515112470046">
<label>53.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Guo</surname><given-names>Z</given-names></name>
<name><surname>Viitanen</surname><given-names>M</given-names></name>
<name><surname>Winblad</surname><given-names>B</given-names></name>
</person-group>. <article-title>Clinical correlates of low blood pressure in very old people: The importance of cognitive impairment</article-title>. <source>J Am Geriatr Soc</source> <year>1997</year>; <volume>45</volume>: <fpage>701</fpage>–<lpage>705</lpage>.</citation>
</ref>
<ref id="bibr54-1474515112470046">
<label>54.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hajjar</surname><given-names>I</given-names></name>
<name><surname>Yang</surname><given-names>F</given-names></name>
<name><surname>Sorond</surname><given-names>F</given-names></name>
<etal/></person-group>. <article-title>A novel aging phenotype of slow gait, impaired executive function, and depressive symptoms: Relationship to blood pressure and other cardiovascular risks</article-title>. <source>J Gerontol A Biol Sci Med Sci</source> <year>2009</year>; <volume>64</volume>: <fpage>994</fpage>–<lpage>1001</lpage>.</citation>
</ref>
<ref id="bibr55-1474515112470046">
<label>55.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Trojano</surname><given-names>L</given-names></name>
<name><surname>Antonelli Incalzi</surname><given-names>R</given-names></name>
<name><surname>Acanfora</surname><given-names>D</given-names></name>
<etal/></person-group>. <article-title>Cognitive impairment: A key feature of congestive heart failure in the elderly</article-title>. <source>J Neurol</source> <year>2003</year>; <volume>250</volume>: <fpage>1456</fpage>–<lpage>1463</lpage>.</citation>
</ref>
<ref id="bibr56-1474515112470046">
<label>56.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bittner</surname><given-names>V</given-names></name>
<name><surname>Weiner</surname><given-names>DH</given-names></name>
<name><surname>Yusuf</surname><given-names>S</given-names></name>
<etal/></person-group>. <article-title>Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators</article-title>. <source>JAMA</source> <year>1993</year>; <volume>270</volume>: <fpage>1702</fpage>–<lpage>1707</lpage>.</citation>
</ref>
<ref id="bibr57-1474515112470046">
<label>57.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gott</surname><given-names>M</given-names></name>
<name><surname>Barnes</surname><given-names>S</given-names></name>
<name><surname>Parker</surname><given-names>C</given-names></name>
<etal/></person-group>. <article-title>Predictors of the quality of life of older people with heart failure recruited from primary care</article-title>. <source>Age Ageing</source> <year>2006</year>; <volume>35</volume>: <fpage>172</fpage>–<lpage>177</lpage>.</citation>
</ref>
<ref id="bibr58-1474515112470046">
<label>58.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Konstam</surname><given-names>V</given-names></name>
<name><surname>Salem</surname><given-names>D</given-names></name>
<name><surname>Pouleur</surname><given-names>H</given-names></name>
<etal/></person-group>. <article-title>Baseline quality of life as a predictor of mortality and hospitalization in 5,025 patients with congestive heart failure. SOLVD Investigations. Studies of Left Ventricular Dysfunction Investigators</article-title>. <source>Am J Cardiol</source> <year>1996</year>; <volume>78</volume>: <fpage>890</fpage>–<lpage>895</lpage>.</citation>
</ref>
<ref id="bibr59-1474515112470046">
<label>59.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kubo</surname><given-names>SH</given-names></name>
<name><surname>Schulman</surname><given-names>S</given-names></name>
<name><surname>Starling</surname><given-names>RC</given-names></name>
<etal/></person-group>. <article-title>Development and validation of a patient questionnaire to determine New York Heart Association classification</article-title>. <source>J Card Fail</source> <year>2004</year>; <volume>10</volume>: <fpage>228</fpage>–<lpage>235</lpage>.</citation>
</ref>
<ref id="bibr60-1474515112470046">
<label>60.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Heckman</surname><given-names>GA</given-names></name>
<name><surname>Patterson</surname><given-names>CJ</given-names></name>
<name><surname>Demers</surname><given-names>C</given-names></name>
<etal/></person-group>. <article-title>Heart failure and cognitive impairment: Challenges and opportunities</article-title>. <source>Clin Interv Aging</source> <year>2007</year>; <volume>2</volume>: <fpage>209</fpage>–<lpage>218</lpage>.</citation>
</ref>
<ref id="bibr61-1474515112470046">
<label>61.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Alosco</surname><given-names>ML</given-names></name>
<name><surname>Spitznagel</surname><given-names>MB</given-names></name>
<name><surname>Raz</surname><given-names>N</given-names></name>
<etal/></person-group>. <article-title>The 2-Minute Step Test is independently associated with cognitive function in older adults with heart failure</article-title>. <source>Aging Clin Exp Res</source> <year>2011</year></citation>
</ref>
<ref id="bibr62-1474515112470046">
<label>62.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Beer</surname><given-names>C</given-names></name>
<name><surname>Ebenezer</surname><given-names>E</given-names></name>
<name><surname>Fenner</surname><given-names>S</given-names></name>
<etal/></person-group>. <article-title>Contributors to cognitive impairment in congestive heart failure: A pilot case-control study</article-title>. <source>Intern Med J</source> <year>2009</year>; <volume>39</volume>: <fpage>600</fpage>–<lpage>605</lpage>.</citation>
</ref>
<ref id="bibr63-1474515112470046">
<label>63.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gorkin</surname><given-names>L</given-names></name>
<name><surname>Norvell</surname><given-names>NK</given-names></name>
<name><surname>Rosen</surname><given-names>RC</given-names></name>
<etal/></person-group>. <article-title>Assessment of quality of life as observed from the baseline data of the Studies of Left Ventricular Dysfunction (SOLVD) trial quality-of-life substudy</article-title>. <source>Am J Cardiol</source> <year>1993</year>; <volume>71</volume>: <fpage>1069</fpage>–<lpage>1073</lpage>.</citation>
</ref>
<ref id="bibr64-1474515112470046">
<label>64.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kerola</surname><given-names>T</given-names></name>
<name><surname>Nieminen</surname><given-names>T</given-names></name>
<name><surname>Hartikainen</surname><given-names>S</given-names></name>
<etal/></person-group>. <article-title>B-type natriuretic peptide as a predictor of declining cognitive function and dementia – a cohort study of an elderly general population with a 5-year follow-up</article-title>. <source>Ann Med</source> <year>2010</year>; <volume>42</volume>: <fpage>207</fpage>–<lpage>215</lpage>.</citation>
</ref>
<ref id="bibr65-1474515112470046">
<label>65.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pressler</surname><given-names>SJ</given-names></name>
<name><surname>Subramanian</surname><given-names>U</given-names></name>
<name><surname>Kareken</surname><given-names>D</given-names></name>
<etal/></person-group>. <article-title>Cognitive deficits in chronic heart failure</article-title>. <source>Nurs Res</source> <year>2010</year>; <volume>59</volume>: <fpage>127</fpage>–<lpage>139</lpage>.</citation>
</ref>
<ref id="bibr66-1474515112470046">
<label>66.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Callegari</surname><given-names>S</given-names></name>
<name><surname>Majani</surname><given-names>G</given-names></name>
<name><surname>Giardini</surname><given-names>A</given-names></name>
<etal/></person-group>. <article-title>Relationship between cognitive impairment and clinical status in chronic heart failure patients</article-title>. <source>Monaldi Arch Chest Dis</source> <year>2002</year>; <volume>58</volume>: <fpage>19</fpage>–<lpage>25</lpage>.</citation>
</ref>
<ref id="bibr67-1474515112470046">
<label>67.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Omland</surname><given-names>T</given-names></name>
</person-group>. <article-title>Advances in congestive heart failure management in the intensive care unit: B-type natriuretic peptides in evaluation of acute heart failure</article-title>. <source>Crit Care Med</source> <year>2008</year>; <volume>36</volume>: <fpage>S17</fpage>–<lpage>S27</lpage>.</citation>
</ref>
<ref id="bibr68-1474515112470046">
<label>68.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dries</surname><given-names>DL</given-names></name>
<name><surname>Ky</surname><given-names>B</given-names></name>
<name><surname>Wu</surname><given-names>AH</given-names></name>
<etal/></person-group>. <article-title>Simultaneous assessment of unprocessed ProBNP1–108 in addition to processed BNP32 improves identification of high-risk ambulatory patients with heart failure</article-title>. <source>Circ Heart Fail</source> <year>2010</year>; <volume>3</volume>: <fpage>220</fpage>–<lpage>227</lpage>.</citation>
</ref>
<ref id="bibr69-1474515112470046">
<label>69.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Waldo</surname><given-names>SW</given-names></name>
<name><surname>Beede</surname><given-names>J</given-names></name>
<name><surname>Isakson</surname><given-names>S</given-names></name>
<etal/></person-group>. <article-title>Pro-B-type natriuretic peptide levels in acute decompensated heart failure</article-title>. <source>J Am Coll Cardiol</source> <year>2008</year>; <volume>51</volume>: <fpage>1874</fpage>–<lpage>1882</lpage>.</citation>
</ref>
<ref id="bibr70-1474515112470046">
<label>70.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Miller</surname><given-names>WL</given-names></name>
<name><surname>Grill</surname><given-names>DE</given-names></name>
<name><surname>Jaffe</surname><given-names>AS</given-names></name>
</person-group>. <article-title>Comparison of novel pro-BNP(1–108) and standard BNP assays in heart failure patients</article-title>. <source>Clin Chim Acta</source> <year>2012</year>; <volume>413</volume>: <fpage>920</fpage>–<lpage>926</lpage>.</citation>
</ref>
<ref id="bibr71-1474515112470046">
<label>71.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Putzke</surname><given-names>JD</given-names></name>
<name><surname>Williams</surname><given-names>MA</given-names></name>
<name><surname>Rayburn</surname><given-names>BK</given-names></name>
<etal/></person-group>. <article-title>The relationship between cardiac function and neuropsychological status among heart transplant candidates</article-title>. <source>J Card Fail</source> <year>1998</year>; <volume>4</volume>: <fpage>295</fpage>–<lpage>303</lpage>.</citation>
</ref>
<ref id="bibr72-1474515112470046">
<label>72.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McLennan</surname><given-names>SN</given-names></name>
<name><surname>Mathias</surname><given-names>JL</given-names></name>
<name><surname>Brennan</surname><given-names>LC</given-names></name>
<etal/></person-group>.<article-title>Validity of the montreal cognitive assessment (MoCA) as a screening test for mild cognitive impairment (MCI) in a cardiovascular population</article-title>. <source>J Geriatr Psychiatry Neurol</source> <year>2011</year>; <volume>24</volume>: <fpage>33</fpage>–<lpage>38</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>